메뉴 건너뛰기




Volumn 25, Issue 8, 2013, Pages 483-498

Biological dose escalation and hypofractionation: What is there to be gained and how will it best be done?

Author keywords

Biological; Dose escalation; Hypofractionation; Image guided radiotherapy; Prostate cancer; Stereotactic body radiotherapy

Indexed keywords

ANTIANDROGEN; PROSTATE SPECIFIC ANTIGEN;

EID: 84880827823     PISSN: 09366555     EISSN: 14332981     Source Type: Journal    
DOI: 10.1016/j.clon.2013.05.003     Document Type: Article
Times cited : (35)

References (184)
  • 1
    • 25144472058 scopus 로고    scopus 로고
    • Radiotherapeutic techniques for prostate cancer, dose escalation and brachytherapy
    • Khoo V.S. Radiotherapeutic techniques for prostate cancer, dose escalation and brachytherapy. Clin Oncol (R Coll Radiol) 2005, 17(7):560-571.
    • (2005) Clin Oncol (R Coll Radiol) , vol.17 , Issue.7 , pp. 560-571
    • Khoo, V.S.1
  • 2
    • 54049148613 scopus 로고    scopus 로고
    • Update of Dutch multicenter dose-escalation trial of radiotherapy for localized prostate cancer
    • Al-Mamgani A., van Putten W.L., Heemsbergen W.D., et al. Update of Dutch multicenter dose-escalation trial of radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 2008, 72(4):980-988.
    • (2008) Int J Radiat Oncol Biol Phys , vol.72 , Issue.4 , pp. 980-988
    • Al-Mamgani, A.1    van Putten, W.L.2    Heemsbergen, W.D.3
  • 3
    • 34249316816 scopus 로고    scopus 로고
    • Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trial
    • Dearnaley D.P., Sydes M.R., Graham J.D., et al. Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trial. Lancet Oncol 2007, 8(6):475-487.
    • (2007) Lancet Oncol , vol.8 , Issue.6 , pp. 475-487
    • Dearnaley, D.P.1    Sydes, M.R.2    Graham, J.D.3
  • 4
    • 79959335126 scopus 로고    scopus 로고
    • 70 Gy versus 80 Gy in localized prostate cancer: 5-year results of GETUG 06 randomized trial
    • Beckendorf V., Guerif S., Le Prise E., et al. 70 Gy versus 80 Gy in localized prostate cancer: 5-year results of GETUG 06 randomized trial. Int J Radiat Oncol Biol Phys 2011, 80(4):1056-1063.
    • (2011) Int J Radiat Oncol Biol Phys , vol.80 , Issue.4 , pp. 1056-1063
    • Beckendorf, V.1    Guerif, S.2    Le Prise, E.3
  • 5
    • 24644443217 scopus 로고    scopus 로고
    • Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial
    • Zietman A.L., DeSilvio M.L., Slater J.D., et al. Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial. JAMA 2005, 294(10):1233-1239.
    • (2005) JAMA , vol.294 , Issue.10 , pp. 1233-1239
    • Zietman, A.L.1    DeSilvio, M.L.2    Slater, J.D.3
  • 6
    • 0036680314 scopus 로고    scopus 로고
    • Prostate cancer radiation dose response: results of the M. D. Anderson phase III randomized trial
    • Pollack A., Zagars G.K., Starkschall G., et al. Prostate cancer radiation dose response: results of the M. D. Anderson phase III randomized trial. Int J Radiat Oncol Biol Phys 2002, 53(5):1097-1105.
    • (2002) Int J Radiat Oncol Biol Phys , vol.53 , Issue.5 , pp. 1097-1105
    • Pollack, A.1    Zagars, G.K.2    Starkschall, G.3
  • 7
    • 84866643014 scopus 로고    scopus 로고
    • Escalated-dose conformal radiotherapy for localised prostate cancer: long-term overall survival results from the MRC RT01 randomised controlled trial, on behalf of the RT01 investigators
    • Dearnaley D.P., Jovic G., Syndikus I., et al. Escalated-dose conformal radiotherapy for localised prostate cancer: long-term overall survival results from the MRC RT01 randomised controlled trial, on behalf of the RT01 investigators. Eur J Cancer 2011, 47(Suppl. 2):11-12.
    • (2011) Eur J Cancer , vol.47 , Issue.SUPPL. 2 , pp. 11-12
    • Dearnaley, D.P.1    Jovic, G.2    Syndikus, I.3
  • 8
    • 37049023209 scopus 로고    scopus 로고
    • Long-term results of the M. D. Anderson randomized dose-escalation trial for prostate cancer
    • Kuban D.A., Tucker S.L., Dong L., et al. Long-term results of the M. D. Anderson randomized dose-escalation trial for prostate cancer. Int J Radiat Oncol Biol Phys 2008, 70(1):67-74.
    • (2008) Int J Radiat Oncol Biol Phys , vol.70 , Issue.1 , pp. 67-74
    • Kuban, D.A.1    Tucker, S.L.2    Dong, L.3
  • 9
    • 77949509341 scopus 로고    scopus 로고
    • Randomized trial comparing conventional-dose with high-dose conformal radiation therapy in early-stage adenocarcinoma of the prostate: long-term results from proton radiation Oncology Group/American College of Radiology 95-09
    • Zietman A.L., Bae K., Slater J.D., et al. Randomized trial comparing conventional-dose with high-dose conformal radiation therapy in early-stage adenocarcinoma of the prostate: long-term results from proton radiation Oncology Group/American College of Radiology 95-09. J Clin Oncol 2010, 28(7):1106-1111.
    • (2010) J Clin Oncol , vol.28 , Issue.7 , pp. 1106-1111
    • Zietman, A.L.1    Bae, K.2    Slater, J.D.3
  • 10
    • 84880795450 scopus 로고    scopus 로고
    • Phase III pilot study of dose escalation using conformal radiotherapy in prostate cancer: long term follow-up
    • Creak A., Hall E., Horwich A., Eeles R., Huddart R., Dearnaley D. Phase III pilot study of dose escalation using conformal radiotherapy in prostate cancer: long term follow-up. Radiother Oncol 2011, 99(Suppl. 1):S201.
    • (2011) Radiother Oncol , vol.99 , Issue.SUPPL. 1
    • Creak, A.1    Hall, E.2    Horwich, A.3    Eeles, R.4    Huddart, R.5    Dearnaley, D.6
  • 11
    • 1542267900 scopus 로고    scopus 로고
    • The efficacy and sequencing of a short course of androgen suppression on freedom from biochemical failure when administered with radiation therapy for T2-T3 prostate cancer
    • Laverdiere J., Nabid A., De Bedoya L.D., et al. The efficacy and sequencing of a short course of androgen suppression on freedom from biochemical failure when administered with radiation therapy for T2-T3 prostate cancer. J Urol 2004, 171(3):1137-1140.
    • (2004) J Urol , vol.171 , Issue.3 , pp. 1137-1140
    • Laverdiere, J.1    Nabid, A.2    De Bedoya, L.D.3
  • 12
    • 4043153049 scopus 로고    scopus 로고
    • 6-month androgen suppression plus radiation therapy vs radiation therapy alone for patients with clinically localized prostate cancer: a randomized controlled trial
    • D'Amico A.V., Manola J., Loffredo M., et al. 6-month androgen suppression plus radiation therapy vs radiation therapy alone for patients with clinically localized prostate cancer: a randomized controlled trial. Jama 2004, 292(7):821-827.
    • (2004) Jama , vol.292 , Issue.7 , pp. 821-827
    • D'Amico, A.V.1    Manola, J.2    Loffredo, M.3
  • 13
    • 27744507677 scopus 로고    scopus 로고
    • Short-term androgen deprivation and radiotherapy for locally advanced prostate cancer: results from the Trans-Tasman Radiation Oncology Group 96.01 randomised controlled trial
    • Denham J.W., Steigler A., Lamb D.S., et al. Short-term androgen deprivation and radiotherapy for locally advanced prostate cancer: results from the Trans-Tasman Radiation Oncology Group 96.01 randomised controlled trial. Lancet Oncol 2005, 6(11):841-850.
    • (2005) Lancet Oncol , vol.6 , Issue.11 , pp. 841-850
    • Denham, J.W.1    Steigler, A.2    Lamb, D.S.3
  • 14
    • 79960227242 scopus 로고    scopus 로고
    • Radiotherapy and short-term androgen deprivation for localized prostate cancer
    • Jones C.U., Hunt D., McGowan D.G., et al. Radiotherapy and short-term androgen deprivation for localized prostate cancer. N Engl J Med 2011, 365(2):107-118.
    • (2011) N Engl J Med , vol.365 , Issue.2 , pp. 107-118
    • Jones, C.U.1    Hunt, D.2    McGowan, D.G.3
  • 15
    • 68149181748 scopus 로고    scopus 로고
    • Does hormone treatment added to radiotherapy improve outcome in locally advanced prostate cancer?: meta-analysis of randomized trials
    • Bria E., Cuppone F., Giannarelli D., et al. Does hormone treatment added to radiotherapy improve outcome in locally advanced prostate cancer?: meta-analysis of randomized trials. Cancer 2009, 115(15):3446-3456.
    • (2009) Cancer , vol.115 , Issue.15 , pp. 3446-3456
    • Bria, E.1    Cuppone, F.2    Giannarelli, D.3
  • 16
    • 70350228288 scopus 로고    scopus 로고
    • Adjuvant hormone therapy for localised and locally advanced prostate carcinoma: a systematic review and meta-analysis of randomised trials
    • Shelley M.D., Kumar S., Coles B., et al. Adjuvant hormone therapy for localised and locally advanced prostate carcinoma: a systematic review and meta-analysis of randomised trials. Cancer Treat Rev 2009, 35(7):540-546.
    • (2009) Cancer Treat Rev , vol.35 , Issue.7 , pp. 540-546
    • Shelley, M.D.1    Kumar, S.2    Coles, B.3
  • 17
    • 84875214812 scopus 로고    scopus 로고
    • Short-term androgen-deprivation therapy improves prostate cancer-specific mortality in intermediate-risk prostate cancer patients undergoing dose-escalated external beam radiation therapy
    • Zumsteg Z.S., Spratt D.E., Pei X., et al. Short-term androgen-deprivation therapy improves prostate cancer-specific mortality in intermediate-risk prostate cancer patients undergoing dose-escalated external beam radiation therapy. Int J Radiat Oncol Biol Phys 2013, 85(4):1012-1017.
    • (2013) Int J Radiat Oncol Biol Phys , vol.85 , Issue.4 , pp. 1012-1017
    • Zumsteg, Z.S.1    Spratt, D.E.2    Pei, X.3
  • 18
    • 33646462895 scopus 로고    scopus 로고
    • Dose-response in radiotherapy for localized prostate cancer: results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy
    • Peeters S.T., Heemsbergen W.D., Koper P.C., et al. Dose-response in radiotherapy for localized prostate cancer: results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy. J Clin Oncol 2006, 24(13):1990-1996.
    • (2006) J Clin Oncol , vol.24 , Issue.13 , pp. 1990-1996
    • Peeters, S.T.1    Heemsbergen, W.D.2    Koper, P.C.3
  • 19
    • 79952701542 scopus 로고    scopus 로고
    • Long-term failure patterns and survival in a randomized dose-escalation trial for prostate cancer. Who dies of disease?
    • Kuban D.A., Levy L.B., Cheung M.R., et al. Long-term failure patterns and survival in a randomized dose-escalation trial for prostate cancer. Who dies of disease?. Int J Radiat Oncol Biol Phys 2011, 79(5):1310-1317.
    • (2011) Int J Radiat Oncol Biol Phys , vol.79 , Issue.5 , pp. 1310-1317
    • Kuban, D.A.1    Levy, L.B.2    Cheung, M.R.3
  • 20
    • 67651112123 scopus 로고    scopus 로고
    • Higher-than-conventional radiation doses in localized prostate cancer treatment: a meta-analysis of randomized, controlled trials
    • Viani G.A., Stefano E.J., Afonso S.L. Higher-than-conventional radiation doses in localized prostate cancer treatment: a meta-analysis of randomized, controlled trials. Int J Radiat Oncol Biol Phys 2009, 74(5):1405-1418.
    • (2009) Int J Radiat Oncol Biol Phys , vol.74 , Issue.5 , pp. 1405-1418
    • Viani, G.A.1    Stefano, E.J.2    Afonso, S.L.3
  • 21
    • 77953576200 scopus 로고    scopus 로고
    • A new method for synthesizing radiation dose-response data from multiple trials applied to prostate cancer
    • Diez P., Vogelius I.S., Bentzen S.M. A new method for synthesizing radiation dose-response data from multiple trials applied to prostate cancer. Int J Radiat Oncol Biol Phys 2010, 77(4):1066-1071.
    • (2010) Int J Radiat Oncol Biol Phys , vol.77 , Issue.4 , pp. 1066-1071
    • Diez, P.1    Vogelius, I.S.2    Bentzen, S.M.3
  • 22
    • 84858698777 scopus 로고    scopus 로고
    • Radiotherapy doses of 80 Gy and higher are associated with lower mortality in men with Gleason score 8 to 10 prostate cancer
    • Pahlajani N., Ruth K.J., Buyyounouski M.K., et al. Radiotherapy doses of 80 Gy and higher are associated with lower mortality in men with Gleason score 8 to 10 prostate cancer. Int J Radiat Oncol Biol Phys 2012, 82(5):1949-1956.
    • (2012) Int J Radiat Oncol Biol Phys , vol.82 , Issue.5 , pp. 1949-1956
    • Pahlajani, N.1    Ruth, K.J.2    Buyyounouski, M.K.3
  • 23
    • 34249287715 scopus 로고    scopus 로고
    • What dose of external-beam radiation is high enough for prostate cancer?
    • Eade T.N., Hanlon A.L., Horwitz E.M., et al. What dose of external-beam radiation is high enough for prostate cancer?. Int J Radiat Oncol Biol Phys 2007, 68(3):682-689.
    • (2007) Int J Radiat Oncol Biol Phys , vol.68 , Issue.3 , pp. 682-689
    • Eade, T.N.1    Hanlon, A.L.2    Horwitz, E.M.3
  • 24
    • 45449093563 scopus 로고    scopus 로고
    • Long-term results of conformal radiotherapy for prostate cancer: impact of dose escalation on biochemical tumor control and distant metastases-free survival outcomes
    • Zelefsky M.J., Yamada Y., Fuks Z., et al. Long-term results of conformal radiotherapy for prostate cancer: impact of dose escalation on biochemical tumor control and distant metastases-free survival outcomes. Int J Radiat Oncol Biol Phys 2008, 71(4):1028-1033.
    • (2008) Int J Radiat Oncol Biol Phys , vol.71 , Issue.4 , pp. 1028-1033
    • Zelefsky, M.J.1    Yamada, Y.2    Fuks, Z.3
  • 25
    • 81855194715 scopus 로고    scopus 로고
    • Long-term results after high-dose radiotherapy and adjuvant hormones in prostate cancer: how curable is high-risk disease?
    • Zapatero A., Garcia-Vicente F., Martin de Vidales C., et al. Long-term results after high-dose radiotherapy and adjuvant hormones in prostate cancer: how curable is high-risk disease?. Int J Radiat Oncol Biol Phys 2011, 81(5):1279-1285.
    • (2011) Int J Radiat Oncol Biol Phys , vol.81 , Issue.5 , pp. 1279-1285
    • Zapatero, A.1    Garcia-Vicente, F.2    Martin de Vidales, C.3
  • 27
    • 77958175874 scopus 로고    scopus 로고
    • When tumor repopulation starts? The onset time of prostate cancer during radiation therapy
    • Gao M., Mayr N.A., Huang Z., et al. When tumor repopulation starts? The onset time of prostate cancer during radiation therapy. Acta Oncol 2010, 49(8):1269-1275.
    • (2010) Acta Oncol , vol.49 , Issue.8 , pp. 1269-1275
    • Gao, M.1    Mayr, N.A.2    Huang, Z.3
  • 28
    • 0034255971 scopus 로고    scopus 로고
    • A comment on proliferation rates in human prostate cancer
    • Hausterman K., Fowler J.F. A comment on proliferation rates in human prostate cancer. Int J Radiat Oncol Biol Phys 2000, 48(1):303.
    • (2000) Int J Radiat Oncol Biol Phys , vol.48 , Issue.1 , pp. 303
    • Hausterman, K.1    Fowler, J.F.2
  • 29
    • 0026010583 scopus 로고
    • Cell kinetics by bromodeoxyuridine labeling and deoxyribonucleic acid ploidy in prostatic carcinoma needle biopsies
    • Scrivner D.L., Meyer J.S., Rujanavech N., et al. Cell kinetics by bromodeoxyuridine labeling and deoxyribonucleic acid ploidy in prostatic carcinoma needle biopsies. J Urol 1991, 146(4):1034-1039.
    • (1991) J Urol , vol.146 , Issue.4 , pp. 1034-1039
    • Scrivner, D.L.1    Meyer, J.S.2    Rujanavech, N.3
  • 30
    • 0024387753 scopus 로고
    • The relevance of alpha/beta ratios determined in vitro for human cell lines to the understanding of in vivo values
    • Deschavanne P.J., Malaise E.P. The relevance of alpha/beta ratios determined in vitro for human cell lines to the understanding of in vivo values. Int J Radiat Biol 1989, 56(5):539-542.
    • (1989) Int J Radiat Biol , vol.56 , Issue.5 , pp. 539-542
    • Deschavanne, P.J.1    Malaise, E.P.2
  • 31
    • 0025259721 scopus 로고
    • Radiation response of xenografts of a human squamous cell carcinoma and a glioblastoma multiforme: a progress report
    • Suit H.D., Zietman A., Tomkinson K., et al. Radiation response of xenografts of a human squamous cell carcinoma and a glioblastoma multiforme: a progress report. Int J Radiat Oncol Biol Phys 1990, 18(2):365-373.
    • (1990) Int J Radiat Oncol Biol Phys , vol.18 , Issue.2 , pp. 365-373
    • Suit, H.D.1    Zietman, A.2    Tomkinson, K.3
  • 32
    • 0036140325 scopus 로고    scopus 로고
    • Direct evidence that prostate tumors show high sensitivity to fractionation (low alpha/beta ratio), similar to late-responding normal tissue
    • Brenner D.J., Martinez A.A., Edmundson G.K., et al. Direct evidence that prostate tumors show high sensitivity to fractionation (low alpha/beta ratio), similar to late-responding normal tissue. Int J Radiat Oncol Biol Phys 2002, 52(1):6-13.
    • (2002) Int J Radiat Oncol Biol Phys , vol.52 , Issue.1 , pp. 6-13
    • Brenner, D.J.1    Martinez, A.A.2    Edmundson, G.K.3
  • 33
    • 0141576615 scopus 로고    scopus 로고
    • The low alpha/beta ratio for prostate cancer: what does the clinical outcome of HDR brachytherapy tell us?
    • Wang J.Z., Li X.A., Yu C.X., et al. The low alpha/beta ratio for prostate cancer: what does the clinical outcome of HDR brachytherapy tell us?. Int J Radiat Oncol Biol Phys 2003, 57(4):1101-1108.
    • (2003) Int J Radiat Oncol Biol Phys , vol.57 , Issue.4 , pp. 1101-1108
    • Wang, J.Z.1    Li, X.A.2    Yu, C.X.3
  • 34
    • 34247097886 scopus 로고    scopus 로고
    • Use of individual fraction size data from 3756 patients to directly determine the alpha/beta ratio of prostate cancer
    • Williams S.G., Taylor J.M., Liu N., et al. Use of individual fraction size data from 3756 patients to directly determine the alpha/beta ratio of prostate cancer. Int J Radiat Oncol Biol Phys 2007, 68(1):24-33.
    • (2007) Int J Radiat Oncol Biol Phys , vol.68 , Issue.1 , pp. 24-33
    • Williams, S.G.1    Taylor, J.M.2    Liu, N.3
  • 35
    • 0034183792 scopus 로고    scopus 로고
    • Is the prostate a/b ratio of 1.5 from brenner & hall a modeling artifact?
    • King C.R., Mayo C.S. Is the prostate a/b ratio of 1.5 from brenner & hall a modeling artifact?. Int J Radiat Oncol Biol Phys 2000, 47(2):536-537.
    • (2000) Int J Radiat Oncol Biol Phys , vol.47 , Issue.2 , pp. 536-537
    • King, C.R.1    Mayo, C.S.2
  • 36
    • 33750297651 scopus 로고    scopus 로고
    • Hypofractionated versus conventionally fractionated radiation therapy for prostate carcinoma: updated results of a phase III randomized trial
    • Yeoh E.E., Holloway R.H., Fraser R.J., et al. Hypofractionated versus conventionally fractionated radiation therapy for prostate carcinoma: updated results of a phase III randomized trial. Int J Radiat Oncol Biol Phys 2006, 66(4):1072-1083.
    • (2006) Int J Radiat Oncol Biol Phys , vol.66 , Issue.4 , pp. 1072-1083
    • Yeoh, E.E.1    Holloway, R.H.2    Fraser, R.J.3
  • 38
    • 0032913909 scopus 로고    scopus 로고
    • Fractionation and protraction for radiotherapy of prostate carcinoma
    • Brenner D.J., Hall E.J. Fractionation and protraction for radiotherapy of prostate carcinoma. Int J Radiat Oncol Biol Phys 1999, 43(5):1095-1101.
    • (1999) Int J Radiat Oncol Biol Phys , vol.43 , Issue.5 , pp. 1095-1101
    • Brenner, D.J.1    Hall, E.J.2
  • 39
    • 84856398974 scopus 로고    scopus 로고
    • Later outcomes and alpha/beta estimate from hypofractionated conformal three-dimensional radiotherapy versus standard fractionation for localized prostate cancer
    • Leborgne F., Fowler J., Leborgne J.H., et al. Later outcomes and alpha/beta estimate from hypofractionated conformal three-dimensional radiotherapy versus standard fractionation for localized prostate cancer. Int J Radiat Oncol Biol Phys 2012, 82(3):1200-1207.
    • (2012) Int J Radiat Oncol Biol Phys , vol.82 , Issue.3 , pp. 1200-1207
    • Leborgne, F.1    Fowler, J.2    Leborgne, J.H.3
  • 40
    • 83955161787 scopus 로고    scopus 로고
    • Dose-fractionation sensitivity of prostate cancer deduced from radiotherapy outcomes of 5,969 patients in seven international institutional datasets: alpha/beta=1.4 (0.9-2.2) Gy
    • Miralbell R., Roberts S.A., Zubizarreta E., et al. Dose-fractionation sensitivity of prostate cancer deduced from radiotherapy outcomes of 5,969 patients in seven international institutional datasets: alpha/beta=1.4 (0.9-2.2) Gy. Int J Radiat Oncol Biol Phys 2012, 82(1):e17-e24.
    • (2012) Int J Radiat Oncol Biol Phys , vol.82 , Issue.1
    • Miralbell, R.1    Roberts, S.A.2    Zubizarreta, E.3
  • 41
    • 0037215315 scopus 로고    scopus 로고
    • How low is the alpha/beta ratio for prostate cancer?
    • Wang J.Z., Guerrero M., Li X.A. How low is the alpha/beta ratio for prostate cancer?. Int J Radiat Oncol Biol Phys 2003, 55(1):194-203.
    • (2003) Int J Radiat Oncol Biol Phys , vol.55 , Issue.1 , pp. 194-203
    • Wang, J.Z.1    Guerrero, M.2    Li, X.A.3
  • 42
    • 18144394315 scopus 로고    scopus 로고
    • Is the alpha-beta ratio of prostate cancer really low? A prospective, non-randomized trial comparing standard and hyperfractionated conformal radiation therapy
    • Valdagni R., Italia C., Montanaro P., et al. Is the alpha-beta ratio of prostate cancer really low? A prospective, non-randomized trial comparing standard and hyperfractionated conformal radiation therapy. Radiother Oncol 2005, 75(1):74-82.
    • (2005) Radiother Oncol , vol.75 , Issue.1 , pp. 74-82
    • Valdagni, R.1    Italia, C.2    Montanaro, P.3
  • 43
    • 78651512165 scopus 로고    scopus 로고
    • Which alpha/beta ratio and half-time of repair are useful for predicting outcomes in prostate cancer?
    • Nickers P., Hermesse J., Deneufbourg J.M., et al. Which alpha/beta ratio and half-time of repair are useful for predicting outcomes in prostate cancer?. Radiother Oncol 2010, 97(3):462-466.
    • (2010) Radiother Oncol , vol.97 , Issue.3 , pp. 462-466
    • Nickers, P.1    Hermesse, J.2    Deneufbourg, J.M.3
  • 44
    • 78649982102 scopus 로고    scopus 로고
    • Confirmation of a low alpha/beta ratio for prostate cancer treated by external beam radiation therapy alone using a post-treatment repeated-measures model for PSA dynamics
    • Proust-Lima C., Taylor J.M., Secher S., et al. Confirmation of a low alpha/beta ratio for prostate cancer treated by external beam radiation therapy alone using a post-treatment repeated-measures model for PSA dynamics. Int J Radiat Oncol Biol Phys 2011, 79(1):195-201.
    • (2011) Int J Radiat Oncol Biol Phys , vol.79 , Issue.1 , pp. 195-201
    • Proust-Lima, C.1    Taylor, J.M.2    Secher, S.3
  • 45
    • 84871382056 scopus 로고    scopus 로고
    • Meta-analysis of the alpha/beta ratio for prostate cancer in the presence of an overall time factor: bad news, good news, or no news?
    • Vogelius I.R., Bentzen S.M. Meta-analysis of the alpha/beta ratio for prostate cancer in the presence of an overall time factor: bad news, good news, or no news?. Int J Radiat Oncol Biol Phys 2013, 85(1):89-94.
    • (2013) Int J Radiat Oncol Biol Phys , vol.85 , Issue.1 , pp. 89-94
    • Vogelius, I.R.1    Bentzen, S.M.2
  • 46
    • 84867552706 scopus 로고    scopus 로고
    • Prostate alpha/beta revisited - an analysis of clinical results from 14 168 patients
    • Dasu A., Toma-Dasu I. Prostate alpha/beta revisited - an analysis of clinical results from 14 168 patients. Acta Oncol 2012, 51(8):963-974.
    • (2012) Acta Oncol , vol.51 , Issue.8 , pp. 963-974
    • Dasu, A.1    Toma-Dasu, I.2
  • 47
    • 0038724753 scopus 로고    scopus 로고
    • What hypofractionated protocols should be tested for prostate cancer?
    • Fowler J.F., Ritter M.A., Chappell R.J., et al. What hypofractionated protocols should be tested for prostate cancer?. Int J Radiat Oncol Biol Phys 2003, 56(4):1093-1104.
    • (2003) Int J Radiat Oncol Biol Phys , vol.56 , Issue.4 , pp. 1093-1104
    • Fowler, J.F.1    Ritter, M.A.2    Chappell, R.J.3
  • 48
    • 7444265874 scopus 로고    scopus 로고
    • Fractionation and late rectal toxicity
    • Brenner D.J. Fractionation and late rectal toxicity. Int J Radiat Oncol Biol Phys 2004, 60(4):1013-1015.
    • (2004) Int J Radiat Oncol Biol Phys , vol.60 , Issue.4 , pp. 1013-1015
    • Brenner, D.J.1
  • 49
    • 80052786190 scopus 로고    scopus 로고
    • Estimation of alpha/beta for late rectal toxicity based on RTOG 94-06
    • Tucker S.L., Thames H.D., Michalski J.M., et al. Estimation of alpha/beta for late rectal toxicity based on RTOG 94-06. Int J Radiat Oncol Biol Phys 2011, 81(2):600-605.
    • (2011) Int J Radiat Oncol Biol Phys , vol.81 , Issue.2 , pp. 600-605
    • Tucker, S.L.1    Thames, H.D.2    Michalski, J.M.3
  • 50
    • 5744247185 scopus 로고    scopus 로고
    • Comparison of in vitro and in vivo alpha/beta ratios for prostate cancer
    • Carlson D.J., Stewart R.D., Li X.A., et al. Comparison of in vitro and in vivo alpha/beta ratios for prostate cancer. Phys Med Biol 2004, 49(19):4477-4491.
    • (2004) Phys Med Biol , vol.49 , Issue.19 , pp. 4477-4491
    • Carlson, D.J.1    Stewart, R.D.2    Li, X.A.3
  • 51
    • 0042383102 scopus 로고    scopus 로고
    • How low is the alpha/beta ratio for prostate cancer? In regard to Wang, et al., IJROBP 2003;55:194-203
    • author reply 595-596
    • Fowler J.F., Ritter M.A., Fenwick J.D., et al. How low is the alpha/beta ratio for prostate cancer? In regard to Wang, et al., IJROBP 2003;55:194-203. Int J Radiat Oncol Biol Phys 2003, 57(2):593-595. author reply 595-596.
    • (2003) Int J Radiat Oncol Biol Phys , vol.57 , Issue.2 , pp. 593-595
    • Fowler, J.F.1    Ritter, M.A.2    Fenwick, J.D.3
  • 52
    • 0036535274 scopus 로고    scopus 로고
    • Is the alpha/beta for prostate tumors really low? In regard to Fowler et al., IJROBP 2001;50:1021-1031
    • author reply 1428
    • Dale R.G., Jones B. Is the alpha/beta for prostate tumors really low? In regard to Fowler et al., IJROBP 2001;50:1021-1031. Int J Radiat Oncol Biol Phys 2002, 52(5):1427-1428. author reply 1428.
    • (2002) Int J Radiat Oncol Biol Phys , vol.52 , Issue.5 , pp. 1427-1428
    • Dale, R.G.1    Jones, B.2
  • 53
    • 23244463067 scopus 로고    scopus 로고
    • The alpha/beta ratio for prostate cancer: what is it, really?
    • Bentzen S.M., Ritter M.A. The alpha/beta ratio for prostate cancer: what is it, really?. Radiother Oncol 2005, 76(1):1-3.
    • (2005) Radiother Oncol , vol.76 , Issue.1 , pp. 1-3
    • Bentzen, S.M.1    Ritter, M.A.2
  • 54
    • 0042884208 scopus 로고    scopus 로고
    • Incorporating clinical measurements of hypoxia into tumor local control modeling of prostate cancer: implications for the alpha/beta ratio
    • Nahum A.E., Movsas B., Horwitz E.M., et al. Incorporating clinical measurements of hypoxia into tumor local control modeling of prostate cancer: implications for the alpha/beta ratio. Int J Radiat Oncol Biol Phys 2003, 57(2):391-401.
    • (2003) Int J Radiat Oncol Biol Phys , vol.57 , Issue.2 , pp. 391-401
    • Nahum, A.E.1    Movsas, B.2    Horwitz, E.M.3
  • 55
    • 34248594934 scopus 로고    scopus 로고
    • Is the alpha/beta value for prostate tumours low enough to be safely used in clinical trials?
    • Dasu A. Is the alpha/beta value for prostate tumours low enough to be safely used in clinical trials?. Clin Oncol (R Coll Radiol) 2007, 19(5):289-301.
    • (2007) Clin Oncol (R Coll Radiol) , vol.19 , Issue.5 , pp. 289-301
    • Dasu, A.1
  • 56
    • 77953962354 scopus 로고    scopus 로고
    • The role of overall treatment time in the outcome of radiotherapy of prostate cancer: an analysis of biochemical failure in 4839 men treated between 1987 and 1995
    • Thames H.D., Kuban D., Levy L.B., et al. The role of overall treatment time in the outcome of radiotherapy of prostate cancer: an analysis of biochemical failure in 4839 men treated between 1987 and 1995. Radiother Oncol 2010, 96(1):6-12.
    • (2010) Radiother Oncol , vol.96 , Issue.1 , pp. 6-12
    • Thames, H.D.1    Kuban, D.2    Levy, L.B.3
  • 57
    • 56349144290 scopus 로고    scopus 로고
    • Does treatment duration affect outcome after radiotherapy for prostate cancer?
    • D'Ambrosio D.J., Li T., Horwitz E.M., et al. Does treatment duration affect outcome after radiotherapy for prostate cancer?. Int J Radiat Oncol Biol Phys 2008, 72(5):1402-1407.
    • (2008) Int J Radiat Oncol Biol Phys , vol.72 , Issue.5 , pp. 1402-1407
    • D'Ambrosio, D.J.1    Li, T.2    Horwitz, E.M.3
  • 58
    • 77953961599 scopus 로고    scopus 로고
    • A prospective phase III randomized trial of hypofractionation versus conventional fractionation in patients with high-risk prostate cancer
    • Arcangeli G., Saracino B., Gomellini S., et al. A prospective phase III randomized trial of hypofractionation versus conventional fractionation in patients with high-risk prostate cancer. Int J Radiat Oncol Biol Phys 2010, 78(1):11-18.
    • (2010) Int J Radiat Oncol Biol Phys , vol.78 , Issue.1 , pp. 11-18
    • Arcangeli, G.1    Saracino, B.2    Gomellini, S.3
  • 59
    • 79951942962 scopus 로고    scopus 로고
    • Hypofractionation results in reduced tumor cell kill compared to conventional fractionation for tumors with regions of hypoxia
    • Carlson D.J., Keall P.J., Loo B.W., et al. Hypofractionation results in reduced tumor cell kill compared to conventional fractionation for tumors with regions of hypoxia. Int J Radiat Oncol Biol Phys 2011, 79(4):1188-1195.
    • (2011) Int J Radiat Oncol Biol Phys , vol.79 , Issue.4 , pp. 1188-1195
    • Carlson, D.J.1    Keall, P.J.2    Loo, B.W.3
  • 60
    • 24944526722 scopus 로고    scopus 로고
    • Randomized trial comparing two fractionation schedules for patients with localized prostate cancer
    • Lukka H., Hayter C., Julian J.A., et al. Randomized trial comparing two fractionation schedules for patients with localized prostate cancer. J Clin Oncol 2005, 23(25):6132-6138.
    • (2005) J Clin Oncol , vol.23 , Issue.25 , pp. 6132-6138
    • Lukka, H.1    Hayter, C.2    Julian, J.A.3
  • 61
    • 34547431049 scopus 로고    scopus 로고
    • Hypofractionated intensity-modulated radiotherapy (70 Gy at 2.5 Gy per fraction) for localized prostate cancer: Cleveland Clinic experience
    • Kupelian P.A., Willoughby T.R., Reddy C.A., et al. Hypofractionated intensity-modulated radiotherapy (70 Gy at 2.5 Gy per fraction) for localized prostate cancer: Cleveland Clinic experience. Int J Radiat Oncol Biol Phys 2007, 68(5):1424-1430.
    • (2007) Int J Radiat Oncol Biol Phys , vol.68 , Issue.5 , pp. 1424-1430
    • Kupelian, P.A.1    Willoughby, T.R.2    Reddy, C.A.3
  • 62
    • 33745197548 scopus 로고    scopus 로고
    • Outcome analysis of 300 prostate cancer patients treated with neoadjuvant androgen deprivation and hypofractionated radiotherapy
    • Higgins G.S., McLaren D.B., Kerr G.R., et al. Outcome analysis of 300 prostate cancer patients treated with neoadjuvant androgen deprivation and hypofractionated radiotherapy. Int J Radiat Oncol Biol Phys 2006, 65(4):982-989.
    • (2006) Int J Radiat Oncol Biol Phys , vol.65 , Issue.4 , pp. 982-989
    • Higgins, G.S.1    McLaren, D.B.2    Kerr, G.R.3
  • 63
    • 35448944905 scopus 로고    scopus 로고
    • Phase II trial of hypofractionated image-guided intensity-modulated radiotherapy for localized prostate adenocarcinoma
    • Martin J.M., Rosewall T., Bayley A., et al. Phase II trial of hypofractionated image-guided intensity-modulated radiotherapy for localized prostate adenocarcinoma. Int J Radiat Oncol Biol Phys 2007, 69(4):1084-1089.
    • (2007) Int J Radiat Oncol Biol Phys , vol.69 , Issue.4 , pp. 1084-1089
    • Martin, J.M.1    Rosewall, T.2    Bayley, A.3
  • 64
    • 79960102464 scopus 로고    scopus 로고
    • A Phase II trial of arc-based hypofractionated intensity-modulated radiotherapy in localized prostate cancer
    • Lock M., Best L., Wong E., et al. A Phase II trial of arc-based hypofractionated intensity-modulated radiotherapy in localized prostate cancer. Int J Radiat Oncol Biol Phys 2011, 80(5):1306-1315.
    • (2011) Int J Radiat Oncol Biol Phys , vol.80 , Issue.5 , pp. 1306-1315
    • Lock, M.1    Best, L.2    Wong, E.3
  • 65
    • 81855166965 scopus 로고    scopus 로고
    • Treating intermediate-risk prostate cancer with hypofractionated external beam radiotherapy alone
    • Faria S., Dal Pra A., Cury F., et al. Treating intermediate-risk prostate cancer with hypofractionated external beam radiotherapy alone. Radiother Oncol 2011, 101(3):486-489.
    • (2011) Radiother Oncol , vol.101 , Issue.3 , pp. 486-489
    • Faria, S.1    Dal Pra, A.2    Cury, F.3
  • 66
    • 81855185482 scopus 로고    scopus 로고
    • Hypofractionated versus conventionally fractionated radiotherapy for prostate carcinoma: final results of phase III randomized trial
    • Yeoh E.E., Botten R.J., Butters J., et al. Hypofractionated versus conventionally fractionated radiotherapy for prostate carcinoma: final results of phase III randomized trial. Int J Radiat Oncol Biol Phys 2011, 81(5):1271-1278.
    • (2011) Int J Radiat Oncol Biol Phys , vol.81 , Issue.5 , pp. 1271-1278
    • Yeoh, E.E.1    Botten, R.J.2    Butters, J.3
  • 67
    • 84855336943 scopus 로고    scopus 로고
    • Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: preliminary safety results from the CHHiP randomised controlled trial
    • Dearnaley D., Syndikus I., Sumo G., et al. Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: preliminary safety results from the CHHiP randomised controlled trial. Lancet Oncol 2012, 13(1):43-54.
    • (2012) Lancet Oncol , vol.13 , Issue.1 , pp. 43-54
    • Dearnaley, D.1    Syndikus, I.2    Sumo, G.3
  • 68
    • 84872047075 scopus 로고    scopus 로고
    • Hypofractionated high-dose radiation therapy for prostate cancer: long-term results of a multi-institutional phase II trial
    • Fonteyne V., Soete G., Arcangeli S., et al. Hypofractionated high-dose radiation therapy for prostate cancer: long-term results of a multi-institutional phase II trial. Int J Radiat Oncol Biol Phys 2012, 84(4):e483-e490.
    • (2012) Int J Radiat Oncol Biol Phys , vol.84 , Issue.4
    • Fonteyne, V.1    Soete, G.2    Arcangeli, S.3
  • 69
    • 84869144788 scopus 로고    scopus 로고
    • Updated results and patterns of failure in a randomized hypofractionation trial for high-risk prostate cancer
    • Arcangeli S., Strigari L., Gomellini S., et al. Updated results and patterns of failure in a randomized hypofractionation trial for high-risk prostate cancer. Int J Radiat Oncol Biol Phys 2012, 84(5):1172-1178.
    • (2012) Int J Radiat Oncol Biol Phys , vol.84 , Issue.5 , pp. 1172-1178
    • Arcangeli, S.1    Strigari, L.2    Gomellini, S.3
  • 70
    • 38149102436 scopus 로고    scopus 로고
    • Question of dose, fractionation and technique: ingredients for testing hypofractionation in prostate cancer-the CHHiP trial
    • Khoo V.S., Dearnaley D.P. Question of dose, fractionation and technique: ingredients for testing hypofractionation in prostate cancer-the CHHiP trial. Clin Oncol (R Coll Radiol) 2008, 20(1):12-14.
    • (2008) Clin Oncol (R Coll Radiol) , vol.20 , Issue.1 , pp. 12-14
    • Khoo, V.S.1    Dearnaley, D.P.2
  • 71
    • 38149088769 scopus 로고    scopus 로고
    • A comparison of treatment planning techniques used in two randomised UK external beam radiotherapy trials for localised prostate cancer
    • South C.P., Khoo V.S., Naismith O., et al. A comparison of treatment planning techniques used in two randomised UK external beam radiotherapy trials for localised prostate cancer. Clin Oncol (R Coll Radiol) 2008, 20(1):15-21.
    • (2008) Clin Oncol (R Coll Radiol) , vol.20 , Issue.1 , pp. 15-21
    • South, C.P.1    Khoo, V.S.2    Naismith, O.3
  • 72
    • 79951953933 scopus 로고    scopus 로고
    • Acute and late toxicity in a randomized trial of conventional versus hypofractionated three-dimensional conformal radiotherapy for prostate cancer
    • Arcangeli G., Fowler J., Gomellini S., et al. Acute and late toxicity in a randomized trial of conventional versus hypofractionated three-dimensional conformal radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 2011, 79(4):1013-1021.
    • (2011) Int J Radiat Oncol Biol Phys , vol.79 , Issue.4 , pp. 1013-1021
    • Arcangeli, G.1    Fowler, J.2    Gomellini, S.3
  • 73
    • 30544434287 scopus 로고    scopus 로고
    • Dosimetry and preliminary acute toxicity in the first 100 men treated for prostate cancer on a randomized hypofractionation dose escalation trial
    • Pollack A., Hanlon A.L., Horwitz E.M., et al. Dosimetry and preliminary acute toxicity in the first 100 men treated for prostate cancer on a randomized hypofractionation dose escalation trial. Int J Radiat Oncol Biol Phys 2006, 64(2):518-526.
    • (2006) Int J Radiat Oncol Biol Phys , vol.64 , Issue.2 , pp. 518-526
    • Pollack, A.1    Hanlon, A.L.2    Horwitz, E.M.3
  • 74
    • 84855308494 scopus 로고    scopus 로고
    • Five year results of a randomized external beam radiotherapy hypofractionation trial for prostate cancer
    • Pollack A., Walker G., Buyyounouski M., et al. Five year results of a randomized external beam radiotherapy hypofractionation trial for prostate cancer. Int J Radiat Oncol Biol Phys 2011, 81(Suppl. 2):S1.
    • (2011) Int J Radiat Oncol Biol Phys , vol.81 , Issue.SUPPL. 2
    • Pollack, A.1    Walker, G.2    Buyyounouski, M.3
  • 75
    • 84855302012 scopus 로고    scopus 로고
    • Preliminary report of a randomized dose escalation trial for prostate cancer using hypofractionation
    • Kuban D., Nogueras-Gonzalez G.M., Hamblin L., et al. Preliminary report of a randomized dose escalation trial for prostate cancer using hypofractionation. Int J Radiat Oncol Biol Phys 2010, 78(Suppl. 3):S58-S59.
    • (2010) Int J Radiat Oncol Biol Phys , vol.78 , Issue.SUPPL. 3
    • Kuban, D.1    Nogueras-Gonzalez, G.M.2    Hamblin, L.3
  • 76
    • 0025313292 scopus 로고
    • Carcinoma of prostate treated by radical external beam radiotherapy using hypofractionation. Twenty-two years' experience (1962-1984)
    • Lloyd-Davies R.W., Collins C.D., Swan A.V. Carcinoma of prostate treated by radical external beam radiotherapy using hypofractionation. Twenty-two years' experience (1962-1984). Urology 1990, 36(2):107-111.
    • (1990) Urology , vol.36 , Issue.2 , pp. 107-111
    • Lloyd-Davies, R.W.1    Collins, C.D.2    Swan, A.V.3
  • 77
    • 0026250035 scopus 로고
    • Radical external beam radiotherapy for localized carcinoma of the prostate using a hypofractionation technique
    • Collins C.D. Radical external beam radiotherapy for localized carcinoma of the prostate using a hypofractionation technique. Clin Oncol (R Coll Radiol) 1991, 3(6):358.
    • (1991) Clin Oncol (R Coll Radiol) , vol.3 , Issue.6 , pp. 358
    • Collins, C.D.1
  • 78
    • 84876157925 scopus 로고    scopus 로고
    • Prostate radiotherapy for men with metastatic disease: a new comparison in the STAMPEDE trial
    • Parker C.C., Sydes M.R., Mason M.D., et al. Prostate radiotherapy for men with metastatic disease: a new comparison in the STAMPEDE trial. Clin Oncol (R Coll Radiol) 2013, 25(5):318-320.
    • (2013) Clin Oncol (R Coll Radiol) , vol.25 , Issue.5 , pp. 318-320
    • Parker, C.C.1    Sydes, M.R.2    Mason, M.D.3
  • 79
    • 78650982500 scopus 로고    scopus 로고
    • Stereotactic body radiotherapy for low-risk prostate cancer: five-year outcomes
    • Freeman D.E., King C.R. Stereotactic body radiotherapy for low-risk prostate cancer: five-year outcomes. Radiat Oncol 2011, 6:3.
    • (2011) Radiat Oncol , vol.6 , pp. 3
    • Freeman, D.E.1    King, C.R.2
  • 80
    • 33847248003 scopus 로고    scopus 로고
    • Stereotactic hypofractionated accurate radiotherapy of the prostate (SHARP), 33.5 Gy in five fractions for localized disease: first clinical trial results
    • Madsen B.L., Hsi R.A., Pham H.T., et al. Stereotactic hypofractionated accurate radiotherapy of the prostate (SHARP), 33.5 Gy in five fractions for localized disease: first clinical trial results. Int J Radiat Oncol Biol Phys 2007, 67(4):1099-1105.
    • (2007) Int J Radiat Oncol Biol Phys , vol.67 , Issue.4 , pp. 1099-1105
    • Madsen, B.L.1    Hsi, R.A.2    Pham, H.T.3
  • 81
    • 55149089265 scopus 로고    scopus 로고
    • Phase I/II study of a five-fraction hypofractionated accelerated radiotherapy treatment for low-risk localised prostate cancer: early results of pHART3
    • Tang C.I., Loblaw D.A., Cheung P., et al. Phase I/II study of a five-fraction hypofractionated accelerated radiotherapy treatment for low-risk localised prostate cancer: early results of pHART3. Clin Oncol (R Coll Radiol) 2008, 20(10):729-737.
    • (2008) Clin Oncol (R Coll Radiol) , vol.20 , Issue.10 , pp. 729-737
    • Tang, C.I.1    Loblaw, D.A.2    Cheung, P.3
  • 82
    • 84859944222 scopus 로고    scopus 로고
    • Pathological, toxicity and quality of life outcomes in a five-fraction hypofractionated accelerated radiotherapy treatment using standard linear accelerators and gold seed fiducials
    • abstract 186
    • Loblaw D., C.P., T.C.I., et al. Pathological, toxicity and quality of life outcomes in a five-fraction hypofractionated accelerated radiotherapy treatment using standard linear accelerators and gold seed fiducials. J Clin Oncol 2012, 30(Suppl. 5). abstract 186.
    • (2012) J Clin Oncol , vol.30 , Issue.SUPPL. 5
    • Loblaw, D.C.P.T.C.I.1
  • 83
    • 84879026771 scopus 로고    scopus 로고
    • Five-year biochemical control rates for stereotactic body radiotherapy for organ confined prostate cancer: a multi-institutional pooled analysis
    • Katz A. Five-year biochemical control rates for stereotactic body radiotherapy for organ confined prostate cancer: a multi-institutional pooled analysis. Int J Radiat Oncol Biol Phys 2012, 8(3):s147-s148.
    • (2012) Int J Radiat Oncol Biol Phys , vol.8 , Issue.3
    • Katz, A.1
  • 84
    • 84880831394 scopus 로고    scopus 로고
    • Long-term efficacy of stereotactic body radiotherapy for localized prostate cancer: a multi-institutional pooled analysis
    • abstract 9
    • Kupelian P., Katz A., Freeman D., et al. Long-term efficacy of stereotactic body radiotherapy for localized prostate cancer: a multi-institutional pooled analysis. J Clin Oncol 2013, 31(Suppl.6). abstract 9.
    • (2013) J Clin Oncol , vol.31 , Issue.SUPPL.6
    • Kupelian, P.1    Katz, A.2    Freeman, D.3
  • 85
    • 84880811846 scopus 로고    scopus 로고
    • Stereotactic body radiotherapy for intermediate-risk organ-confined prostate cancer: interim toxicity and quality of life outcomes from a multi-institutional study
    • Meier R., Kaplan I., Beckman A., et al. Stereotactic body radiotherapy for intermediate-risk organ-confined prostate cancer: interim toxicity and quality of life outcomes from a multi-institutional study. Int J Radiat Oncol Biol Phys 2012, 84(3):S148.
    • (2012) Int J Radiat Oncol Biol Phys , vol.84 , Issue.3
    • Meier, R.1    Kaplan, I.2    Beckman, A.3
  • 86
    • 84880817627 scopus 로고    scopus 로고
    • Available from
    • Widmark A. HYPO-RT-PC Trial 2012, Available from: http://www.controlled- trials.com/ISRCTN45905321.
    • (2012) HYPO-RT-PC Trial
    • Widmark, A.1
  • 87
    • 84880801412 scopus 로고    scopus 로고
    • Prostate Advances in Comparative Evidence (PACE). Available from: ).
    • Prostate Advances in Comparative Evidence (PACE) 2011. Available from: ). http://www.clinicaltrials.gov/ct2/show/NCT01584258.
    • (2011)
  • 88
    • 84873319205 scopus 로고    scopus 로고
    • High-dose-rate interstitial brachytherapy as monotherapy for clinically localized prostate cancer: treatment evolution and mature results
    • Zamboglou N., Tselis N., Baltas D., et al. High-dose-rate interstitial brachytherapy as monotherapy for clinically localized prostate cancer: treatment evolution and mature results. Int J Radiat Oncol Biol Phys 2013, 85(3):672-678.
    • (2013) Int J Radiat Oncol Biol Phys , vol.85 , Issue.3 , pp. 672-678
    • Zamboglou, N.1    Tselis, N.2    Baltas, D.3
  • 89
    • 84857921010 scopus 로고    scopus 로고
    • High-dose-rate brachytherapy alone for localized prostate cancer in patients at moderate or high risk of biochemical recurrence
    • Hoskin P., Rojas A., Lowe G., et al. High-dose-rate brachytherapy alone for localized prostate cancer in patients at moderate or high risk of biochemical recurrence. Int J Radiat Oncol Biol Phys 2012, 82(4):1376-1384.
    • (2012) Int J Radiat Oncol Biol Phys , vol.82 , Issue.4 , pp. 1376-1384
    • Hoskin, P.1    Rojas, A.2    Lowe, G.3
  • 90
    • 83555168196 scopus 로고    scopus 로고
    • High dose brachytherapy as monotherapy for intermediate risk prostate cancer
    • Rogers C.L., Alder S.C., Rogers R.L., et al. High dose brachytherapy as monotherapy for intermediate risk prostate cancer. JUrol 2012, 187(1):109-116.
    • (2012) JUrol , vol.187 , Issue.1 , pp. 109-116
    • Rogers, C.L.1    Alder, S.C.2    Rogers, R.L.3
  • 91
    • 84861633557 scopus 로고    scopus 로고
    • High-dose-rate brachytherapy as monotherapy delivered in two fractions within one day for favorable/intermediate-risk prostate cancer: preliminary toxicity data
    • Ghilezan M., Martinez A., Gustason G., et al. High-dose-rate brachytherapy as monotherapy delivered in two fractions within one day for favorable/intermediate-risk prostate cancer: preliminary toxicity data. Int J Radiat Oncol Biol Phys 2012, 83(3):927-932.
    • (2012) Int J Radiat Oncol Biol Phys , vol.83 , Issue.3 , pp. 927-932
    • Ghilezan, M.1    Martinez, A.2    Gustason, G.3
  • 92
    • 41749096128 scopus 로고    scopus 로고
    • A comparison of the use of bony anatomy and internal markers for offline verification and an evaluation of the potential benefit of online and offline verification protocols for prostate radiotherapy
    • McNair H.A., Hansen V.N., Parker C.C., et al. A comparison of the use of bony anatomy and internal markers for offline verification and an evaluation of the potential benefit of online and offline verification protocols for prostate radiotherapy. Int J Radiat Oncol Biol Phys 2008, 71(1):41-50.
    • (2008) Int J Radiat Oncol Biol Phys , vol.71 , Issue.1 , pp. 41-50
    • McNair, H.A.1    Hansen, V.N.2    Parker, C.C.3
  • 94
    • 33845188961 scopus 로고    scopus 로고
    • Influence of the initial rectal distension on posterior margins in primary and postoperative radiotherapy for prostate cancer
    • Pinkawa M., Siluschek J., Gagel B., et al. Influence of the initial rectal distension on posterior margins in primary and postoperative radiotherapy for prostate cancer. Radiother Oncol 2006, 81(3):284-290.
    • (2006) Radiother Oncol , vol.81 , Issue.3 , pp. 284-290
    • Pinkawa, M.1    Siluschek, J.2    Gagel, B.3
  • 95
    • 39749094602 scopus 로고    scopus 로고
    • Evaluation of image-guidance strategies in the treatment of localized prostate cancer
    • Kupelian P.A., Lee C., Langen K.M., et al. Evaluation of image-guidance strategies in the treatment of localized prostate cancer. Int J Radiat Oncol Biol Phys 2008, 70(4):1151-1157.
    • (2008) Int J Radiat Oncol Biol Phys , vol.70 , Issue.4 , pp. 1151-1157
    • Kupelian, P.A.1    Lee, C.2    Langen, K.M.3
  • 96
    • 61349134730 scopus 로고    scopus 로고
    • Influence of daily setup measurements and corrections on the estimated delivered dose during IMRT treatment of prostate cancer patients
    • van Haaren P.M., Bel A., Hofman P., et al. Influence of daily setup measurements and corrections on the estimated delivered dose during IMRT treatment of prostate cancer patients. Radiother Oncol 2009, 90(3):291-298.
    • (2009) Radiother Oncol , vol.90 , Issue.3 , pp. 291-298
    • van Haaren, P.M.1    Bel, A.2    Hofman, P.3
  • 97
    • 78549246733 scopus 로고    scopus 로고
    • Prostate intrafraction motion assessed by simultaneous kilovoltage fluoroscopy at megavoltage delivery I: clinical observations and pattern analysis
    • Adamson J., Wu Q. Prostate intrafraction motion assessed by simultaneous kilovoltage fluoroscopy at megavoltage delivery I: clinical observations and pattern analysis. Int J Radiat Oncol Biol Phys 2010, 78(5):1563-1570.
    • (2010) Int J Radiat Oncol Biol Phys , vol.78 , Issue.5 , pp. 1563-1570
    • Adamson, J.1    Wu, Q.2
  • 98
    • 33645368752 scopus 로고    scopus 로고
    • Influence of intrafraction motion on margins for prostate radiotherapy
    • Litzenberg D.W., Balter J.M., Hadley S.W., et al. Influence of intrafraction motion on margins for prostate radiotherapy. Int J Radiat Oncol Biol Phys 2006, 65(2):548-553.
    • (2006) Int J Radiat Oncol Biol Phys , vol.65 , Issue.2 , pp. 548-553
    • Litzenberg, D.W.1    Balter, J.M.2    Hadley, S.W.3
  • 99
    • 0033037392 scopus 로고    scopus 로고
    • Evaluating the effect of rectal distension and rectal movement on prostate gland position using cine MRI
    • Padhani A.R., Khoo V.S., Suckling J., et al. Evaluating the effect of rectal distension and rectal movement on prostate gland position using cine MRI. Int J Radiat Oncol Biol Phys 1999, 44(3):525-533.
    • (1999) Int J Radiat Oncol Biol Phys , vol.44 , Issue.3 , pp. 525-533
    • Padhani, A.R.1    Khoo, V.S.2    Suckling, J.3
  • 100
    • 45449088673 scopus 로고    scopus 로고
    • Observations on real-time prostate gland motion using electromagnetic tracking
    • Langen K.M., Willoughby T.R., Meeks S.L., et al. Observations on real-time prostate gland motion using electromagnetic tracking. Int J Radiat Oncol Biol Phys 2008, 71(4):1084-1090.
    • (2008) Int J Radiat Oncol Biol Phys , vol.71 , Issue.4 , pp. 1084-1090
    • Langen, K.M.1    Willoughby, T.R.2    Meeks, S.L.3
  • 101
    • 33847328730 scopus 로고    scopus 로고
    • Multi-institutional clinical experience with the Calypso System in localization and continuous, real-time monitoring of the prostate gland during external radiotherapy
    • Kupelian P., Willoughby T., Mahadevan A., et al. Multi-institutional clinical experience with the Calypso System in localization and continuous, real-time monitoring of the prostate gland during external radiotherapy. Int J Radiat Oncol Biol Phys 2007, 67(4):1088-1098.
    • (2007) Int J Radiat Oncol Biol Phys , vol.67 , Issue.4 , pp. 1088-1098
    • Kupelian, P.1    Willoughby, T.2    Mahadevan, A.3
  • 102
    • 49549093853 scopus 로고    scopus 로고
    • Intrafractional motion of the prostate during hypofractionated radiotherapy
    • Xie Y., Djajaputra D., King C.R., et al. Intrafractional motion of the prostate during hypofractionated radiotherapy. Int J Radiat Oncol Biol Phys 2008, 72(1):236-246.
    • (2008) Int J Radiat Oncol Biol Phys , vol.72 , Issue.1 , pp. 236-246
    • Xie, Y.1    Djajaputra, D.2    King, C.R.3
  • 103
    • 78549259670 scopus 로고    scopus 로고
    • Assessment of planning target volume margins for intensity-modulated radiotherapy of the prostate gland: role of daily inter- and intrafraction motion
    • Tanyi J.A., He T., Summers P.A., et al. Assessment of planning target volume margins for intensity-modulated radiotherapy of the prostate gland: role of daily inter- and intrafraction motion. Int J Radiat Oncol Biol Phys 2010, 78(5):1579-1585.
    • (2010) Int J Radiat Oncol Biol Phys , vol.78 , Issue.5 , pp. 1579-1585
    • Tanyi, J.A.1    He, T.2    Summers, P.A.3
  • 104
    • 84867074926 scopus 로고    scopus 로고
    • Large prostate motion produced by anal contraction
    • Onishi H., Kuriyama K., Komiyama T., et al. Large prostate motion produced by anal contraction. Radiother Oncol 2012, 104(3):390-394.
    • (2012) Radiother Oncol , vol.104 , Issue.3 , pp. 390-394
    • Onishi, H.1    Kuriyama, K.2    Komiyama, T.3
  • 105
    • 68649123356 scopus 로고    scopus 로고
    • Inferences about prostate intrafraction motion from pre- and posttreatment volumetric imaging
    • Adamson J., Wu Q. Inferences about prostate intrafraction motion from pre- and posttreatment volumetric imaging. Int J Radiat Oncol Biol Phys 2009, 75(1):260-267.
    • (2009) Int J Radiat Oncol Biol Phys , vol.75 , Issue.1 , pp. 260-267
    • Adamson, J.1    Wu, Q.2
  • 106
    • 0033824006 scopus 로고    scopus 로고
    • A comparison of ventilatory prostate movement in four treatment positions
    • Dawson L.A., Litzenberg D.W., Brock K.K., et al. A comparison of ventilatory prostate movement in four treatment positions. Int J Radiat Oncol Biol Phys 2000, 48(2):319-323.
    • (2000) Int J Radiat Oncol Biol Phys , vol.48 , Issue.2 , pp. 319-323
    • Dawson, L.A.1    Litzenberg, D.W.2    Brock, K.K.3
  • 107
    • 21044451622 scopus 로고    scopus 로고
    • Individualized planning target volumes for intrafraction motion during hypofractionated intensity-modulated radiotherapy boost for prostate cancer
    • Cheung P., Sixel K., Morton G., et al. Individualized planning target volumes for intrafraction motion during hypofractionated intensity-modulated radiotherapy boost for prostate cancer. Int J Radiat Oncol Biol Phys 2005, 62(2):418-425.
    • (2005) Int J Radiat Oncol Biol Phys , vol.62 , Issue.2 , pp. 418-425
    • Cheung, P.1    Sixel, K.2    Morton, G.3
  • 108
    • 84860426181 scopus 로고    scopus 로고
    • Evaluation of the respiratory prostate motion with four-dimensional computed tomography scan acquisitions using three implanted markers
    • Udrescu C., Jalade P., de Bari B., et al. Evaluation of the respiratory prostate motion with four-dimensional computed tomography scan acquisitions using three implanted markers. Radiother Oncol 2012, 103(2):266-269.
    • (2012) Radiother Oncol , vol.103 , Issue.2 , pp. 266-269
    • Udrescu, C.1    Jalade, P.2    de Bari, B.3
  • 109
    • 80255131307 scopus 로고    scopus 로고
    • Use of implanted markers and interportal adjustment with real-time tracking radiotherapy system to reduce intrafraction prostate motion
    • Shimizu S., Osaka Y., Shinohara N., et al. Use of implanted markers and interportal adjustment with real-time tracking radiotherapy system to reduce intrafraction prostate motion. Int J Radiat Oncol Biol Phys 2011, 81(4):e393-e399.
    • (2011) Int J Radiat Oncol Biol Phys , vol.81 , Issue.4
    • Shimizu, S.1    Osaka, Y.2    Shinohara, N.3
  • 110
    • 77951774760 scopus 로고    scopus 로고
    • Electromagnetic tracking of intrafraction prostate displacement in patients externally immobilized in the prone position
    • Bittner N., Butler W.M., Reed J.L., et al. Electromagnetic tracking of intrafraction prostate displacement in patients externally immobilized in the prone position. Int J Radiat Oncol Biol Phys 2010, 77(2):490-495.
    • (2010) Int J Radiat Oncol Biol Phys , vol.77 , Issue.2 , pp. 490-495
    • Bittner, N.1    Butler, W.M.2    Reed, J.L.3
  • 111
    • 84865782173 scopus 로고    scopus 로고
    • Comparison of dose decrement from intrafraction motion for prone and supine prostate radiotherapy
    • Olsen J.R., Parikh P.J., Watts M., et al. Comparison of dose decrement from intrafraction motion for prone and supine prostate radiotherapy. Radiother Oncol 2012, 104(2):199-204.
    • (2012) Radiother Oncol , vol.104 , Issue.2 , pp. 199-204
    • Olsen, J.R.1    Parikh, P.J.2    Watts, M.3
  • 112
    • 0030061461 scopus 로고    scopus 로고
    • Analysis of prostate and seminal vesicle motion: implications for treatment planning
    • Beard C.J., Kijewski P., Bussiere M., et al. Analysis of prostate and seminal vesicle motion: implications for treatment planning. Int J Radiat Oncol Biol Phys 1996, 34(2):451-458.
    • (1996) Int J Radiat Oncol Biol Phys , vol.34 , Issue.2 , pp. 451-458
    • Beard, C.J.1    Kijewski, P.2    Bussiere, M.3
  • 113
    • 36348980426 scopus 로고    scopus 로고
    • Is a 3-mm intrafractional margin sufficient for daily image-guided intensity-modulated radiation therapy of prostate cancer?
    • Melancon A.D., O'Daniel J.C., Zhang L., et al. Is a 3-mm intrafractional margin sufficient for daily image-guided intensity-modulated radiation therapy of prostate cancer?. Radiother Oncol 2007, 85(2):251-259.
    • (2007) Radiother Oncol , vol.85 , Issue.2 , pp. 251-259
    • Melancon, A.D.1    O'Daniel, J.C.2    Zhang, L.3
  • 114
    • 79955610034 scopus 로고    scopus 로고
    • Residual seminal vesicle displacement in marker-based image-guided radiotherapy for prostate cancer and the impact on margin design
    • Smitsmans M.H., de Bois J., Sonke J.J., et al. Residual seminal vesicle displacement in marker-based image-guided radiotherapy for prostate cancer and the impact on margin design. Int J Radiat Oncol Biol Phys 2011, 80(2):590-596.
    • (2011) Int J Radiat Oncol Biol Phys , vol.80 , Issue.2 , pp. 590-596
    • Smitsmans, M.H.1    de Bois, J.2    Sonke, J.J.3
  • 115
    • 80255141829 scopus 로고    scopus 로고
    • Margin evaluation in the presence of deformation, rotation, and translation in prostate and entire seminal vesicle irradiation with daily marker-based setup corrections
    • Mutanga T.F., de Boer H.C., van der Wielen G.J., et al. Margin evaluation in the presence of deformation, rotation, and translation in prostate and entire seminal vesicle irradiation with daily marker-based setup corrections. Int J Radiat Oncol Biol Phys 2011, 81(4):1160-1167.
    • (2011) Int J Radiat Oncol Biol Phys , vol.81 , Issue.4 , pp. 1160-1167
    • Mutanga, T.F.1    de Boer, H.C.2    van der Wielen, G.J.3
  • 116
    • 4444285372 scopus 로고    scopus 로고
    • On-line aSi portal imaging of implanted fiducial markers for the reduction of interfraction error during conformal radiotherapy of prostate carcinoma
    • Chung P.W., Haycocks T., Brown T., et al. On-line aSi portal imaging of implanted fiducial markers for the reduction of interfraction error during conformal radiotherapy of prostate carcinoma. Int J Radiat Oncol Biol Phys 2004, 60(1):329-334.
    • (2004) Int J Radiat Oncol Biol Phys , vol.60 , Issue.1 , pp. 329-334
    • Chung, P.W.1    Haycocks, T.2    Brown, T.3
  • 117
    • 0037966410 scopus 로고    scopus 로고
    • Clinical feasibility study for the use of implanted gold seeds in the prostate as reliable positioning markers during megavoltage irradiation
    • Dehnad H., Nederveen A.J., van der Heide U.A., et al. Clinical feasibility study for the use of implanted gold seeds in the prostate as reliable positioning markers during megavoltage irradiation. Radiother Oncol 2003, 67(3):295-302.
    • (2003) Radiother Oncol , vol.67 , Issue.3 , pp. 295-302
    • Dehnad, H.1    Nederveen, A.J.2    van der Heide, U.A.3
  • 118
    • 67649540781 scopus 로고    scopus 로고
    • Dosimetric impact and theoretical clinical benefits of fiducial markers for dose-escalated prostate cancer radiation treatment
    • Gauthier I., Carrier J.F., Beliveau-Nadeau D., et al. Dosimetric impact and theoretical clinical benefits of fiducial markers for dose-escalated prostate cancer radiation treatment. Int J Radiat Oncol Biol Phys 2009, 74(4):1128-1133.
    • (2009) Int J Radiat Oncol Biol Phys , vol.74 , Issue.4 , pp. 1128-1133
    • Gauthier, I.1    Carrier, J.F.2    Beliveau-Nadeau, D.3
  • 119
    • 22144456659 scopus 로고    scopus 로고
    • Intraprostatic fiducials for localization of the prostate gland: monitoring intermarker distances during radiation therapy to test for marker stability
    • Kupelian P.A., Willoughby T.R., Meeks S.L., et al. Intraprostatic fiducials for localization of the prostate gland: monitoring intermarker distances during radiation therapy to test for marker stability. Int J Radiat Oncol Biol Phys 2005, 62(5):1291-1296.
    • (2005) Int J Radiat Oncol Biol Phys , vol.62 , Issue.5 , pp. 1291-1296
    • Kupelian, P.A.1    Willoughby, T.R.2    Meeks, S.L.3
  • 120
    • 84863106937 scopus 로고    scopus 로고
    • Improved clinical outcomes with high-dose image guided radiotherapy compared with non-IGRT for the treatment of clinically localized prostate cancer
    • Zelefsky M.J., Kollmeier M., Cox B., et al. Improved clinical outcomes with high-dose image guided radiotherapy compared with non-IGRT for the treatment of clinically localized prostate cancer. Int J Radiat Oncol Biol Phys 2012, 84(1):125-129.
    • (2012) Int J Radiat Oncol Biol Phys , vol.84 , Issue.1 , pp. 125-129
    • Zelefsky, M.J.1    Kollmeier, M.2    Cox, B.3
  • 121
    • 77249134524 scopus 로고    scopus 로고
    • The European Society of Therapeutic Radiology and Oncology-European Institute of Radiotherapy (ESTRO-EIR) report on 3D CT-based in-room image guidance systems: a practical and technical review and guide
    • Korreman S., Rasch C., McNair H., et al. The European Society of Therapeutic Radiology and Oncology-European Institute of Radiotherapy (ESTRO-EIR) report on 3D CT-based in-room image guidance systems: a practical and technical review and guide. Radiother Oncol 2010, 94(2):129-144.
    • (2010) Radiother Oncol , vol.94 , Issue.2 , pp. 129-144
    • Korreman, S.1    Rasch, C.2    McNair, H.3
  • 122
    • 84862816268 scopus 로고    scopus 로고
    • Impact of computed tomography image quality on image-guided radiation therapy based on soft tissue registration
    • Morrow N.V., Lawton C.A., Qi X.S., et al. Impact of computed tomography image quality on image-guided radiation therapy based on soft tissue registration. Int J Radiat Oncol Biol Phys 2012, 82(5):e733-e738.
    • (2012) Int J Radiat Oncol Biol Phys , vol.82 , Issue.5
    • Morrow, N.V.1    Lawton, C.A.2    Qi, X.S.3
  • 123
    • 22144485867 scopus 로고    scopus 로고
    • Initial experience with megavoltage (MV) CT guidance for daily prostate alignments
    • Langen K.M., Zhang Y., Andrews R.D., et al. Initial experience with megavoltage (MV) CT guidance for daily prostate alignments. Int J Radiat Oncol Biol Phys 2005, 62(5):1517-1524.
    • (2005) Int J Radiat Oncol Biol Phys , vol.62 , Issue.5 , pp. 1517-1524
    • Langen, K.M.1    Zhang, Y.2    Andrews, R.D.3
  • 124
    • 33846829584 scopus 로고    scopus 로고
    • Comparison of localization performance with implanted fiducial markers and cone-beam computed tomography for on-line image-guided radiotherapy of the prostate
    • Moseley D.J., White E.A., Wiltshire K.L., et al. Comparison of localization performance with implanted fiducial markers and cone-beam computed tomography for on-line image-guided radiotherapy of the prostate. Int J Radiat Oncol Biol Phys 2007, 67(3):942-953.
    • (2007) Int J Radiat Oncol Biol Phys , vol.67 , Issue.3 , pp. 942-953
    • Moseley, D.J.1    White, E.A.2    Wiltshire, K.L.3
  • 125
    • 59649124228 scopus 로고    scopus 로고
    • Prediction of intrafraction prostate motion: accuracy of pre- and post-treatment imaging and intermittent imaging
    • Noel C., Parikh P.J., Roy M., et al. Prediction of intrafraction prostate motion: accuracy of pre- and post-treatment imaging and intermittent imaging. Int J Radiat Oncol Biol Phys 2009, 73(3):692-698.
    • (2009) Int J Radiat Oncol Biol Phys , vol.73 , Issue.3 , pp. 692-698
    • Noel, C.1    Parikh, P.J.2    Roy, M.3
  • 126
    • 61349091065 scopus 로고    scopus 로고
    • High precision transponder localization using a novel electromagnetic positioning system in patients with localized prostate cancer
    • Kindblom J., Ekelund-Olvenmark A.M., Syren H., et al. High precision transponder localization using a novel electromagnetic positioning system in patients with localized prostate cancer. Radiother Oncol 2009, 90(3):307-311.
    • (2009) Radiother Oncol , vol.90 , Issue.3 , pp. 307-311
    • Kindblom, J.1    Ekelund-Olvenmark, A.M.2    Syren, H.3
  • 127
    • 84863609003 scopus 로고    scopus 로고
    • Online image-based monitoring of soft-tissue displacements for radiation therapy of the prostate
    • Schlosser J., Salisbury K., Hristov D. Online image-based monitoring of soft-tissue displacements for radiation therapy of the prostate. Int J Radiat Oncol Biol Phys 2012, 83(5):1633-1640.
    • (2012) Int J Radiat Oncol Biol Phys , vol.83 , Issue.5 , pp. 1633-1640
    • Schlosser, J.1    Salisbury, K.2    Hristov, D.3
  • 128
    • 77958465057 scopus 로고    scopus 로고
    • Tracking accuracy of a real-time fiducial tracking system for patient positioning and monitoring in radiation therapy
    • Shchory T., Schifter D., Lichtman R., et al. Tracking accuracy of a real-time fiducial tracking system for patient positioning and monitoring in radiation therapy. Int J Radiat Oncol Biol Phys 2010, 78(4):1227-1234.
    • (2010) Int J Radiat Oncol Biol Phys , vol.78 , Issue.4 , pp. 1227-1234
    • Shchory, T.1    Schifter, D.2    Lichtman, R.3
  • 129
    • 79551672187 scopus 로고    scopus 로고
    • Performance evaluation of real-time motion tracking using positron emission fudicial markers
    • Chamberland M., Wassenaar R., Spencer B., Xu T. Performance evaluation of real-time motion tracking using positron emission fudicial markers. Med Phy 2011, 38(2):810-819.
    • (2011) Med Phy , vol.38 , Issue.2 , pp. 810-819
    • Chamberland, M.1    Wassenaar, R.2    Spencer, B.3    Xu, T.4
  • 130
    • 84872194357 scopus 로고    scopus 로고
    • Patient positioning based on a radioactive tracer implanted in patients with localized prostate cancer: a performance and safety evaluation
    • de Kruijf W.J., Verstraete J., Neustadter D., et al. Patient positioning based on a radioactive tracer implanted in patients with localized prostate cancer: a performance and safety evaluation. Int J Radiat Oncol Biol Phys 2013, 85(2):555-560.
    • (2013) Int J Radiat Oncol Biol Phys , vol.85 , Issue.2 , pp. 555-560
    • de Kruijf, W.J.1    Verstraete, J.2    Neustadter, D.3
  • 131
    • 0034237797 scopus 로고    scopus 로고
    • The probability of correct target dosage: dose-population histograms for deriving treatment margins in radiotherapy
    • van Herk M., Remeijer P., Rasch C., et al. The probability of correct target dosage: dose-population histograms for deriving treatment margins in radiotherapy. Int J Radiat Oncol Biol Phys 2000, 47(4):1121-1135.
    • (2000) Int J Radiat Oncol Biol Phys , vol.47 , Issue.4 , pp. 1121-1135
    • van Herk, M.1    Remeijer, P.2    Rasch, C.3
  • 132
    • 77953958105 scopus 로고    scopus 로고
    • Intra-fraction prostate displacement in radiotherapy estimated from pre- and post-treatment imaging of patients with implanted fiducial markers
    • Kron T., Thomas J., Fox C., et al. Intra-fraction prostate displacement in radiotherapy estimated from pre- and post-treatment imaging of patients with implanted fiducial markers. Radiother Oncol 2010, 95(2):191-197.
    • (2010) Radiother Oncol , vol.95 , Issue.2 , pp. 191-197
    • Kron, T.1    Thomas, J.2    Fox, C.3
  • 133
    • 42949150341 scopus 로고    scopus 로고
    • Dosimetric consequences of intrafraction prostate motion
    • Li H.S., Chetty I.J., Enke C.A., et al. Dosimetric consequences of intrafraction prostate motion. Int J Radiat Oncol Biol Phys 2008, 71(3):801-812.
    • (2008) Int J Radiat Oncol Biol Phys , vol.71 , Issue.3 , pp. 801-812
    • Li, H.S.1    Chetty, I.J.2    Enke, C.A.3
  • 134
    • 84864751146 scopus 로고    scopus 로고
    • Dosimetric implications of residual seminal vesicle motion in fiducial-guided intensity-modulated radiotherapy for prostate cancer
    • Stenmark M.H., Vineberg K., Ten Haken R.K., et al. Dosimetric implications of residual seminal vesicle motion in fiducial-guided intensity-modulated radiotherapy for prostate cancer. Med Dosim 2012, 37(3):240-244.
    • (2012) Med Dosim , vol.37 , Issue.3 , pp. 240-244
    • Stenmark, M.H.1    Vineberg, K.2    Ten Haken, R.K.3
  • 135
    • 33748945694 scopus 로고    scopus 로고
    • Daily variations in delivered doses in patients treated with radiotherapy for localized prostate cancer
    • Kupelian P.A., Langen K.M., Zeidan O.A., et al. Daily variations in delivered doses in patients treated with radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 2006, 66(3):876-882.
    • (2006) Int J Radiat Oncol Biol Phys , vol.66 , Issue.3 , pp. 876-882
    • Kupelian, P.A.1    Langen, K.M.2    Zeidan, O.A.3
  • 136
    • 50449083967 scopus 로고    scopus 로고
    • Simulated real time image guided intrafraction tracking-delivery for hypofractionated prostate IMRT
    • Hossain S., Xia P., Chuang C., et al. Simulated real time image guided intrafraction tracking-delivery for hypofractionated prostate IMRT. Med Phys 2008, 35(9):4041-4048.
    • (2008) Med Phys , vol.35 , Issue.9 , pp. 4041-4048
    • Hossain, S.1    Xia, P.2    Chuang, C.3
  • 137
    • 0345700623 scopus 로고    scopus 로고
    • Patterns of patient movement during frameless image-guided radiosurgery
    • Murphy M.J., Chang S.D., Gibbs I.C., et al. Patterns of patient movement during frameless image-guided radiosurgery. Int J Radiat Oncol Biol Phys 2003, 55(5):1400-1408.
    • (2003) Int J Radiat Oncol Biol Phys , vol.55 , Issue.5 , pp. 1400-1408
    • Murphy, M.J.1    Chang, S.D.2    Gibbs, I.C.3
  • 138
    • 62649112896 scopus 로고    scopus 로고
    • Intrafraction geometric uncertainties in frameless image-guided radiosurgery
    • Murphy M.J. Intrafraction geometric uncertainties in frameless image-guided radiosurgery. Int J Radiat Oncol Biol Phys 2009, 73(5):1364-1368.
    • (2009) Int J Radiat Oncol Biol Phys , vol.73 , Issue.5 , pp. 1364-1368
    • Murphy, M.J.1
  • 139
    • 0012932486 scopus 로고    scopus 로고
    • Image-guided radiosurgery in the treatment of spinal metastases
    • Murphy M.J., Chang S., Gibbs I., et al. Image-guided radiosurgery in the treatment of spinal metastases. Neurosurg Focus 2001, 11(6):e6.
    • (2001) Neurosurg Focus , vol.11 , Issue.6
    • Murphy, M.J.1    Chang, S.2    Gibbs, I.3
  • 140
    • 0036804489 scopus 로고    scopus 로고
    • On-line correction of beam portals in the treatment of prostate cancer using an endorectal balloon device
    • Ciernik I.F., Baumert B.G., Egli P., et al. On-line correction of beam portals in the treatment of prostate cancer using an endorectal balloon device. Radiother Oncol 2002, 65(1):39-45.
    • (2002) Radiother Oncol , vol.65 , Issue.1 , pp. 39-45
    • Ciernik, I.F.1    Baumert, B.G.2    Egli, P.3
  • 141
    • 79955475427 scopus 로고    scopus 로고
    • Minimal benefit of an endorectal balloon for prostate immobilization as verified by daily localization
    • Hung A.Y., Garzotto M., Kaurin D. Minimal benefit of an endorectal balloon for prostate immobilization as verified by daily localization. Med Dosim 2011, 36(2):195-199.
    • (2011) Med Dosim , vol.36 , Issue.2 , pp. 195-199
    • Hung, A.Y.1    Garzotto, M.2    Kaurin, D.3
  • 142
    • 11144352756 scopus 로고    scopus 로고
    • The effect of an endorectal balloon and off-line correction on the interfraction systematic and random prostate position variations: a comparative study
    • van Lin E.N., van der Vight L.P., Witjes J.A., et al. The effect of an endorectal balloon and off-line correction on the interfraction systematic and random prostate position variations: a comparative study. Int J Radiat Oncol Biol Phys 2005, 61(1):278-288.
    • (2005) Int J Radiat Oncol Biol Phys , vol.61 , Issue.1 , pp. 278-288
    • van Lin, E.N.1    van der Vight, L.P.2    Witjes, J.A.3
  • 143
    • 0036137840 scopus 로고    scopus 로고
    • The influence of a rectal balloon tube as internal immobilization device on variations of volumes and dose-volume histograms during treatment course of conformal radiotherapy for prostate cancer
    • Wachter S., Gerstner N., Dorner D., et al. The influence of a rectal balloon tube as internal immobilization device on variations of volumes and dose-volume histograms during treatment course of conformal radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 2002, 52(1):91-100.
    • (2002) Int J Radiat Oncol Biol Phys , vol.52 , Issue.1 , pp. 91-100
    • Wachter, S.1    Gerstner, N.2    Dorner, D.3
  • 144
    • 81855166698 scopus 로고    scopus 로고
    • Real-time study of prostate intrafraction motion during external beam radiotherapy with daily endorectal balloon
    • Both S., Wang K.K., Plastaras J.P., et al. Real-time study of prostate intrafraction motion during external beam radiotherapy with daily endorectal balloon. Int J Radiat Oncol Biol Phys 2011, 81(5):1302-1309.
    • (2011) Int J Radiat Oncol Biol Phys , vol.81 , Issue.5 , pp. 1302-1309
    • Both, S.1    Wang, K.K.2    Plastaras, J.P.3
  • 145
    • 84861097020 scopus 로고    scopus 로고
    • An endorectal balloon reduces intrafraction prostate motion during radiotherapy
    • Smeenk R.J., Louwe R.J., Langen K.M., et al. An endorectal balloon reduces intrafraction prostate motion during radiotherapy. Int J Radiat Oncol Biol Phys 2012, 83(2):661-669.
    • (2012) Int J Radiat Oncol Biol Phys , vol.83 , Issue.2 , pp. 661-669
    • Smeenk, R.J.1    Louwe, R.J.2    Langen, K.M.3
  • 146
    • 84863522512 scopus 로고    scopus 로고
    • Dosimetric and deformation effects of image-guided interventions during stereotactic body radiation therapy of the prostate using an endorectal balloon
    • Jones B.L., Gan G., Diot Q., et al. Dosimetric and deformation effects of image-guided interventions during stereotactic body radiation therapy of the prostate using an endorectal balloon. Med Phys 2012, 39(6):3080-3088.
    • (2012) Med Phys , vol.39 , Issue.6 , pp. 3080-3088
    • Jones, B.L.1    Gan, G.2    Diot, Q.3
  • 147
    • 84867308394 scopus 로고    scopus 로고
    • Reduction of prostate intrafraction motion using gas-release rectal balloons
    • Su Z., Zhao T., Li Z., et al. Reduction of prostate intrafraction motion using gas-release rectal balloons. Med Phys 2012, 39(10):5869-5873.
    • (2012) Med Phys , vol.39 , Issue.10 , pp. 5869-5873
    • Su, Z.1    Zhao, T.2    Li, Z.3
  • 148
    • 70349326442 scopus 로고    scopus 로고
    • Anal wall sparing effect of an endorectal balloon in 3D conformal and intensity-modulated prostate radiotherapy
    • Smeenk R.J., van Lin E.N., van Kollenburg P., et al. Anal wall sparing effect of an endorectal balloon in 3D conformal and intensity-modulated prostate radiotherapy. Radiother Oncol 2009, 93(1):131-136.
    • (2009) Radiother Oncol , vol.93 , Issue.1 , pp. 131-136
    • Smeenk, R.J.1    van Lin, E.N.2    van Kollenburg, P.3
  • 149
    • 81855164942 scopus 로고    scopus 로고
    • Endorectal balloon reduces anorectal doses in post-prostatectomy intensity-modulated radiotherapy
    • Smeenk R.J., van Lin E.N., van Kollenburg P., et al. Endorectal balloon reduces anorectal doses in post-prostatectomy intensity-modulated radiotherapy. Radiother Oncol 2011, 101(3):465-470.
    • (2011) Radiother Oncol , vol.101 , Issue.3 , pp. 465-470
    • Smeenk, R.J.1    van Lin, E.N.2    van Kollenburg, P.3
  • 150
    • 24944514551 scopus 로고    scopus 로고
    • Rectal wall sparing effect of three different endorectal balloons in 3D conformal and IMRT prostate radiotherapy
    • van Lin E.N., Hoffmann A.L., van Kollenburg P., et al. Rectal wall sparing effect of three different endorectal balloons in 3D conformal and IMRT prostate radiotherapy. Int J Radiat Oncol Biol Phys 2005, 63(2):565-576.
    • (2005) Int J Radiat Oncol Biol Phys , vol.63 , Issue.2 , pp. 565-576
    • van Lin, E.N.1    Hoffmann, A.L.2    van Kollenburg, P.3
  • 151
    • 33846849181 scopus 로고    scopus 로고
    • Reduced late rectal mucosal changes after prostate three-dimensional conformal radiotherapy with endorectal balloon as observed in repeated endoscopy
    • van Lin E.N., Kristinsson J., Philippens M.E., et al. Reduced late rectal mucosal changes after prostate three-dimensional conformal radiotherapy with endorectal balloon as observed in repeated endoscopy. Int J Radiat Oncol Biol Phys 2007, 67(3):799-811.
    • (2007) Int J Radiat Oncol Biol Phys , vol.67 , Issue.3 , pp. 799-811
    • van Lin, E.N.1    Kristinsson, J.2    Philippens, M.E.3
  • 152
    • 84880786734 scopus 로고    scopus 로고
    • Relationship between dose distribution on the rectal wall and late toxicity after prostate radiotherapy with an endorectal balloon
    • van der Geest A., Buettner F., Gulliford S., et al. Relationship between dose distribution on the rectal wall and late toxicity after prostate radiotherapy with an endorectal balloon. Radiother Oncol 2011, 99:s180.
    • (2011) Radiother Oncol , vol.99
    • van der Geest, A.1    Buettner, F.2    Gulliford, S.3
  • 153
    • 0035284066 scopus 로고    scopus 로고
    • Intensity-modulated radiation therapy (IMRT) for prostate cancer with the use of a rectal balloon for prostate immobilization: acute toxicity and dose-volume analysis
    • Teh B.S., Mai W.Y., Uhl B.M., et al. Intensity-modulated radiation therapy (IMRT) for prostate cancer with the use of a rectal balloon for prostate immobilization: acute toxicity and dose-volume analysis. Int J Radiat Oncol Biol Phys 2001, 49(3):705-712.
    • (2001) Int J Radiat Oncol Biol Phys , vol.49 , Issue.3 , pp. 705-712
    • Teh, B.S.1    Mai, W.Y.2    Uhl, B.M.3
  • 154
    • 0032936814 scopus 로고    scopus 로고
    • The importance of computed tomography slice thickness in radiographic patient positioning for radiosurgery
    • Murphy M.J. The importance of computed tomography slice thickness in radiographic patient positioning for radiosurgery. Med Phys 1999, 26(2):171-175.
    • (1999) Med Phys , vol.26 , Issue.2 , pp. 171-175
    • Murphy, M.J.1
  • 155
    • 84866675044 scopus 로고    scopus 로고
    • Intensity modulated proton and photon therapy for early prostate cancer with or without transperineal injection of a polyethylen glycol spacer: a treatment planning comparison study
    • Weber D.C., Zilli T., Vallee J.P., et al. Intensity modulated proton and photon therapy for early prostate cancer with or without transperineal injection of a polyethylen glycol spacer: a treatment planning comparison study. Int J Radiat Oncol Biol Phys 2012, 84(3):e311-318.
    • (2012) Int J Radiat Oncol Biol Phys , vol.84 , Issue.3
    • Weber, D.C.1    Zilli, T.2    Vallee, J.P.3
  • 156
    • 80054089400 scopus 로고    scopus 로고
    • Application of a spacer gel to optimize three-dimensional conformal and intensity modulated radiotherapy for prostate cancer
    • Pinkawa M., Corral N.E., Caffaro M., et al. Application of a spacer gel to optimize three-dimensional conformal and intensity modulated radiotherapy for prostate cancer. Radiother Oncol 2011, 100(3):436-441.
    • (2011) Radiother Oncol , vol.100 , Issue.3 , pp. 436-441
    • Pinkawa, M.1    Corral, N.E.2    Caffaro, M.3
  • 158
    • 84880796090 scopus 로고    scopus 로고
    • Focal therapy for prostate cancer: rationale and treatment opportunities
    • in press.
    • Kasivisvanathan V, Emberton M, Ahmed HU. Focal therapy for prostate cancer: rationale and treatment opportunities. Clin Oncol, in press.
    • Clin Oncol
    • Kasivisvanathan, V.1    Emberton, M.2    Ahmed, H.U.3
  • 159
    • 84858699596 scopus 로고    scopus 로고
    • Does local recurrence of prostate cancer after radiation therapy occur at the site of primary tumor? Results of a longitudinal MRI and MRSI study
    • Arrayeh E., Westphalen A.C., Kurhanewicz J., et al. Does local recurrence of prostate cancer after radiation therapy occur at the site of primary tumor? Results of a longitudinal MRI and MRSI study. Int J Radiat Oncol Biol Phys 2012, 82(5):e787-e793.
    • (2012) Int J Radiat Oncol Biol Phys , vol.82 , Issue.5
    • Arrayeh, E.1    Westphalen, A.C.2    Kurhanewicz, J.3
  • 160
    • 0036644081 scopus 로고    scopus 로고
    • Analysis of intraprostatic failures in patients treated with hormonal therapy and radiotherapy: implications for conformal therapyplanning
    • Cellini N., Morganti A.G., Mattiucci G.C., et al. Analysis of intraprostatic failures in patients treated with hormonal therapy and radiotherapy: implications for conformal therapyplanning. Int J Radiat Oncol Biol Phys 2002, 53(3):595-599.
    • (2002) Int J Radiat Oncol Biol Phys , vol.53 , Issue.3 , pp. 595-599
    • Cellini, N.1    Morganti, A.G.2    Mattiucci, G.C.3
  • 161
    • 34547850190 scopus 로고    scopus 로고
    • Clinically significant prostate cancer local recurrence after radiation therapy occurs at the site of primary tumor: magnetic resonance imaging and step-section pathology evidence
    • Pucar D., Hricak H., Shukla-Dave A., et al. Clinically significant prostate cancer local recurrence after radiation therapy occurs at the site of primary tumor: magnetic resonance imaging and step-section pathology evidence. Int J Radiat Oncol Biol Phys 2007, 69(1):62-69.
    • (2007) Int J Radiat Oncol Biol Phys , vol.69 , Issue.1 , pp. 62-69
    • Pucar, D.1    Hricak, H.2    Shukla-Dave, A.3
  • 162
    • 79955594690 scopus 로고    scopus 로고
    • Parameters favorable to intraprostatic radiation dose escalation in men with localized prostate cancer
    • Housri N., Ning H., Ondos J., et al. Parameters favorable to intraprostatic radiation dose escalation in men with localized prostate cancer. Int J Radiat Oncol Biol Phys 2011, 80(2):614-620.
    • (2011) Int J Radiat Oncol Biol Phys , vol.80 , Issue.2 , pp. 614-620
    • Housri, N.1    Ning, H.2    Ondos, J.3
  • 163
    • 84880799877 scopus 로고    scopus 로고
    • To deliver a focal boost during whole prostate gland irradiation using Cyberknife
    • Tree A., Khoo V.S., van As N. To deliver a focal boost during whole prostate gland irradiation using Cyberknife. Radiotherapy and Oncology 2012, 103(Suppl. 1):s494.
    • (2012) Radiotherapy and Oncology , vol.103 , Issue.SUPPL. 1
    • Tree, A.1    Khoo, V.S.2    van As, N.3
  • 164
    • 79551500579 scopus 로고    scopus 로고
    • Volumetric arc therapy and intensity-modulated radiotherapy for primary prostate radiotherapy with simultaneous integrated boost to intraprostatic lesion with 6 and 18 MV: a planning comparison study
    • Ost P., Speleers B., De Meerleer G., et al. Volumetric arc therapy and intensity-modulated radiotherapy for primary prostate radiotherapy with simultaneous integrated boost to intraprostatic lesion with 6 and 18 MV: a planning comparison study. Int J Radiat Oncol Biol Phys 2011, 79(3):920-926.
    • (2011) Int J Radiat Oncol Biol Phys , vol.79 , Issue.3 , pp. 920-926
    • Ost, P.1    Speleers, B.2    De Meerleer, G.3
  • 165
    • 0036204888 scopus 로고    scopus 로고
    • Potential improvements in the therapeutic ratio of prostate cancer irradiation: dose escalation of pathologically identified tumour nodules using intensity modulated radiotherapy
    • Nutting C.M., Corbishley C.M., Sanchez-Nieto B., et al. Potential improvements in the therapeutic ratio of prostate cancer irradiation: dose escalation of pathologically identified tumour nodules using intensity modulated radiotherapy. Br J Radiol 2002, 75(890):151-161.
    • (2002) Br J Radiol , vol.75 , Issue.890 , pp. 151-161
    • Nutting, C.M.1    Corbishley, C.M.2    Sanchez-Nieto, B.3
  • 166
    • 52949134110 scopus 로고    scopus 로고
    • Intensity-modulated radiotherapy as primary therapy for prostate cancer: report on acute toxicity after dose escalation with simultaneous integrated boost to intraprostatic lesion
    • Fonteyne V., Villeirs G., Speleers B., et al. Intensity-modulated radiotherapy as primary therapy for prostate cancer: report on acute toxicity after dose escalation with simultaneous integrated boost to intraprostatic lesion. Int J Radiat Oncol Biol Phys 2008, 72(3):799-807.
    • (2008) Int J Radiat Oncol Biol Phys , vol.72 , Issue.3 , pp. 799-807
    • Fonteyne, V.1    Villeirs, G.2    Speleers, B.3
  • 167
    • 22444444787 scopus 로고    scopus 로고
    • The magnetic resonance detected intraprostatic lesion in prostate cancer: planning and delivery of intensity-modulated radiotherapy
    • De Meerleer G., Villeirs G., Bral S., et al. The magnetic resonance detected intraprostatic lesion in prostate cancer: planning and delivery of intensity-modulated radiotherapy. Radiother Oncol 2005, 75(3):325-333.
    • (2005) Radiother Oncol , vol.75 , Issue.3 , pp. 325-333
    • De Meerleer, G.1    Villeirs, G.2    Bral, S.3
  • 168
    • 84856253220 scopus 로고    scopus 로고
    • Dose-escalation using intensity-modulated radiotherapy for prostate cancer - evaluation of quality of life with and without (18)F-choline PET-CT detected simultaneous integrated boost
    • Pinkawa M., Piroth M.D., Holy R., et al. Dose-escalation using intensity-modulated radiotherapy for prostate cancer - evaluation of quality of life with and without (18)F-choline PET-CT detected simultaneous integrated boost. Radiat Oncol 2012, 7:14.
    • (2012) Radiat Oncol , vol.7 , pp. 14
    • Pinkawa, M.1    Piroth, M.D.2    Holy, R.3
  • 169
    • 12844259042 scopus 로고    scopus 로고
    • A dose-escalation trial with the adaptive radiotherapy process as a delivery system in localized prostate cancer: analysis of chronic toxicity
    • Brabbins D., Martinez A., Yan D., et al. A dose-escalation trial with the adaptive radiotherapy process as a delivery system in localized prostate cancer: analysis of chronic toxicity. Int J Radiat Oncol Biol Phys 2005, 61(2):400-408.
    • (2005) Int J Radiat Oncol Biol Phys , vol.61 , Issue.2 , pp. 400-408
    • Brabbins, D.1    Martinez, A.2    Yan, D.3
  • 170
    • 0035424531 scopus 로고    scopus 로고
    • Improvement in dose escalation using the process of adaptive radiotherapy combined with three-dimensional conformal or intensity-modulated beams for prostate cancer
    • Martinez A.A., Yan D., Lockman D., et al. Improvement in dose escalation using the process of adaptive radiotherapy combined with three-dimensional conformal or intensity-modulated beams for prostate cancer. Int J Radiat Oncol Biol Phys 2001, 50(5):1226-1234.
    • (2001) Int J Radiat Oncol Biol Phys , vol.50 , Issue.5 , pp. 1226-1234
    • Martinez, A.A.1    Yan, D.2    Lockman, D.3
  • 171
    • 26944493434 scopus 로고    scopus 로고
    • Phase II dose escalation study of image-guided adaptive radiotherapy for prostate cancer: use of dose-volume constraints to achieve rectal isotoxicity
    • Vargas C., Yan D., Kestin L.L., et al. Phase II dose escalation study of image-guided adaptive radiotherapy for prostate cancer: use of dose-volume constraints to achieve rectal isotoxicity. Int J Radiat Oncol Biol Phys 2005, 63(1):141-149.
    • (2005) Int J Radiat Oncol Biol Phys , vol.63 , Issue.1 , pp. 141-149
    • Vargas, C.1    Yan, D.2    Kestin, L.L.3
  • 172
    • 84861607617 scopus 로고    scopus 로고
    • Adaptive image-guided radiotherapy (igrt) eliminates the risk of biochemical failure caused by the bias of rectal distension in prostate cancer treatment planning: clinical evidence
    • Park S.S., Yan D., McGrath S., et al. Adaptive image-guided radiotherapy (igrt) eliminates the risk of biochemical failure caused by the bias of rectal distension in prostate cancer treatment planning: clinical evidence. Int J Radiat Oncol Biol Phys 2012, 83(3):947-952.
    • (2012) Int J Radiat Oncol Biol Phys , vol.83 , Issue.3 , pp. 947-952
    • Park, S.S.1    Yan, D.2    McGrath, S.3
  • 173
    • 37049020907 scopus 로고    scopus 로고
    • Adaptive radiotherapy for prostate cancer using kilovoltage cone-beam computed tomography: first clinical results
    • Nijkamp J., Pos F.J., Nuver T.T., et al. Adaptive radiotherapy for prostate cancer using kilovoltage cone-beam computed tomography: first clinical results. Int J Radiat Oncol Biol Phys 2008, 70(1):75-82.
    • (2008) Int J Radiat Oncol Biol Phys , vol.70 , Issue.1 , pp. 75-82
    • Nijkamp, J.1    Pos, F.J.2    Nuver, T.T.3
  • 174
    • 84858705381 scopus 로고    scopus 로고
    • Practical method of adaptive radiotherapy for prostate cancer using real-time electromagnetic tracking
    • Olsen J.R., Noel C.E., Baker K., et al. Practical method of adaptive radiotherapy for prostate cancer using real-time electromagnetic tracking. Int J Radiat Oncol Biol Phys 2012, 82(5):1903-1911.
    • (2012) Int J Radiat Oncol Biol Phys , vol.82 , Issue.5 , pp. 1903-1911
    • Olsen, J.R.1    Noel, C.E.2    Baker, K.3
  • 175
    • 33748304451 scopus 로고    scopus 로고
    • A deformable image registration method to handle distended rectums in prostate cancer radiotherapy
    • Gao S., Zhang L., Wang H., et al. A deformable image registration method to handle distended rectums in prostate cancer radiotherapy. Med Phys 2006, 33(9):3304-3312.
    • (2006) Med Phys , vol.33 , Issue.9 , pp. 3304-3312
    • Gao, S.1    Zhang, L.2    Wang, H.3
  • 176
    • 81855228758 scopus 로고    scopus 로고
    • Deformable registration using edge-preserving scale space for adaptive image-guided radiation therapy
    • Li D., Wang H., Yin Y., et al. Deformable registration using edge-preserving scale space for adaptive image-guided radiation therapy. J Appl Clin Med Phys 2011, 12(4):3527.
    • (2011) J Appl Clin Med Phys , vol.12 , Issue.4 , pp. 3527
    • Li, D.1    Wang, H.2    Yin, Y.3
  • 177
    • 49549113402 scopus 로고    scopus 로고
    • Performance evaluation of automatic anatomy segmentation algorithm on repeat or four-dimensional computed tomography images using deformable image registration method
    • Wang H., Garden A.S., Zhang L., et al. Performance evaluation of automatic anatomy segmentation algorithm on repeat or four-dimensional computed tomography images using deformable image registration method. Int J Radiat Oncol Biol Phys 2008, 72(1):210-219.
    • (2008) Int J Radiat Oncol Biol Phys , vol.72 , Issue.1 , pp. 210-219
    • Wang, H.1    Garden, A.S.2    Zhang, L.3
  • 178
    • 84867295192 scopus 로고    scopus 로고
    • Methodology for registration of distended rectums in pelvic CT studies
    • Rodriguez-Vila B., Garcia-Vicente F., Gomez E.J. Methodology for registration of distended rectums in pelvic CT studies. Med Phys 2012, 39(10):6351-6359.
    • (2012) Med Phys , vol.39 , Issue.10 , pp. 6351-6359
    • Rodriguez-Vila, B.1    Garcia-Vicente, F.2    Gomez, E.J.3
  • 179
    • 77955506120 scopus 로고    scopus 로고
    • Online adaptive replanning method for prostate radiotherapy
    • Ahunbay E.E., Peng C., Holmes S., et al. Online adaptive replanning method for prostate radiotherapy. Int J Radiat Oncol Biol Phys 2010, 77(5):1561-1572.
    • (2010) Int J Radiat Oncol Biol Phys , vol.77 , Issue.5 , pp. 1561-1572
    • Ahunbay, E.E.1    Peng, C.2    Holmes, S.3
  • 180
    • 41849130277 scopus 로고    scopus 로고
    • On-line re-optimization of prostate IMRT plans for adaptive radiation therapy
    • Wu Q.J., Thongphiew D., Wang Z., et al. On-line re-optimization of prostate IMRT plans for adaptive radiation therapy. Phys Med Biol 2008, 53(3):673-691.
    • (2008) Phys Med Biol , vol.53 , Issue.3 , pp. 673-691
    • Wu, Q.J.1    Thongphiew, D.2    Wang, Z.3
  • 181
    • 84862740171 scopus 로고    scopus 로고
    • First clinical release of an online, adaptive, aperture-based image-guided radiotherapy strategy in intensity-modulated radiotherapy to correct for inter- and intrafractional rotations of the prostate
    • Deutschmann H., Kametriser G., Steininger P., et al. First clinical release of an online, adaptive, aperture-based image-guided radiotherapy strategy in intensity-modulated radiotherapy to correct for inter- and intrafractional rotations of the prostate. Int J Radiat Oncol Biol Phys 2012, 83(5):1624-1632.
    • (2012) Int J Radiat Oncol Biol Phys , vol.83 , Issue.5 , pp. 1624-1632
    • Deutschmann, H.1    Kametriser, G.2    Steininger, P.3
  • 182
    • 34447322061 scopus 로고    scopus 로고
    • A strategy to correct for intrafraction target translation in conformal prostate radiotherapy: simulation results
    • Keall P.J., Lauve A.D., Hagan M.P., et al. A strategy to correct for intrafraction target translation in conformal prostate radiotherapy: simulation results. Med Phys 2007, 34(6):1944-1951.
    • (2007) Med Phys , vol.34 , Issue.6 , pp. 1944-1951
    • Keall, P.J.1    Lauve, A.D.2    Hagan, M.P.3
  • 183
    • 78650029661 scopus 로고    scopus 로고
    • Electromagnetic-guided dynamic multileaf collimator tracking enables motion management for intensity-modulated arc therapy
    • Keall P.J., Sawant A., Cho B., et al. Electromagnetic-guided dynamic multileaf collimator tracking enables motion management for intensity-modulated arc therapy. Int J Radiat Oncol Biol Phys 2011, 79(1):312-320.
    • (2011) Int J Radiat Oncol Biol Phys , vol.79 , Issue.1 , pp. 312-320
    • Keall, P.J.1    Sawant, A.2    Cho, B.3
  • 184
    • 84861092799 scopus 로고    scopus 로고
    • Image-based dynamic multileaf collimator tracking of moving targets during intensity-modulated arc therapy
    • Poulsen P.R., Fledelius W., Cho B., et al. Image-based dynamic multileaf collimator tracking of moving targets during intensity-modulated arc therapy. Int J Radiat Oncol Biol Phys 2012, 83(2):e265-e271.
    • (2012) Int J Radiat Oncol Biol Phys , vol.83 , Issue.2
    • Poulsen, P.R.1    Fledelius, W.2    Cho, B.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.